- 2026.02.09
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated prazosin hydrochloride Tablet, uncoated 5.476 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 9/02/2026 omeprazole Capsule, enteric 20 mg Current Limited Availability Manufacturing 9/02/2026 amlodipine besilate~atorvastatin calcium trihydrate Tablet, film coated 13.88 mg~86.751 mg Current Limited Availability Manufacturing 9/02/2026 cabergoline Tablet, uncoated 1 mg Anticipated Available Manufacturing 9/02/2026 atovaquone~proguanil hydrochloride Tablet, film coated 62.5 mg~25 mg Resolved Available Unexpected increase in consumer demand 9/02/2026 salbutamol sulfate Inhalation 2.4 mg/mL Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 6/02/2026 paclitaxel Injection, powder for 100 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 6/02/2026 ciprofloxacin hydrochloride Tablet, film coated 555 mg Resolved Available Manufacturing 6/02/2026 ciprofloxacin hydrochloride Tablet, film coated 832.5 mg Current Unavailable Manufacturing 6/02/2026 lamotrigine Tablet, chewable 200 mg Current Limited Availability Manufacturing 6/02/2026 olanzapine Tablet, orally disintegrating 10 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 6/02/2026 enalapril maleate Tablet 5 mg Resolved Available Manufacturing 6/02/2026 quetiapine fumarate Tablet, modified release 172.695 mg Resolved Available Manufacturing 6/02/2026 clindamycin hydrochloride Capsule, hard 162.87 mg Current Limited Availability Manufacturing 6/02/2026 clindamycin hydrochloride Capsule, hard 162.87 mg Anticipated Available Manufacturing 6/02/2026 levetiracetam Injection, intravenous infusion 100 mg/mL Anticipated Available Manufacturing 6/02/2026 ethinylestradiol~levonorgestrel Tablet, uncoated 30 microgram~150 microgram Anticipated Available Manufacturing 6/02/2026 citalopram hydrobromide Tablet, film coated 12.495 mg Resolved Available Manufacturing 6/02/2026 ezetimibe Tablet, uncoated 10 mg Resolved Available Unexpected increase in consumer demand 6/02/2026 tranexamic acid Tablet, film coated 500 mg Current Unavailable Manufacturing 6/02/2026 hydrochlorothiazide~olmesartan medoxomil Tablet 12.5 mg~40 mg Resolved Available Manufacturing 6/02/2026 eplerenone Tablet, film coated 50 mg Anticipated Available Manufacturing 6/02/2026 timolol maleate~latanoprost Eye Drops, solution 6.83 mg/mL~.05 mg/mL Current Unavailable Manufacturing 6/02/2026 midodrine hydrochloride Tablet 2.5 mg Current Unavailable Manufacturing 6/02/2026 paclitaxel Injection, powder for 100 mg Current Limited Availability Manufacturing 6/02/2026 lamotrigine Tablet, chewable 200 mg Current Unavailable Manufacturing 6/02/2026 anastrozole Tablet, film coated 1 mg Anticipated Available Manufacturing 6/02/2026 clindamycin phosphate Cream 22.8 mg/g Anticipated Available Unexpected increase in consumer demand 6/02/2026 imipramine hydrochloride Tablet, sugar coated 25 mg Current Unavailable Manufacturing 6/02/2026 vinorelbine tartrate Capsule, soft 27.7 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 6/02/2026 vinorelbine tartrate Capsule, soft 41.55 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 6/02/2026 ceftazidime pentahydrate Injection, powder for 1.164 g Anticipated Available Unexpected increase in consumer demand 5/02/2026 varenicline tartrate~varenicline tartrate Tablet, film coated .86 mg~1.71 mg Anticipated Available Manufacturing 5/02/2026 nimodipine Tablet, film coated 30 mg Current Limited Availability Manufacturing 5/02/2026 formoterol fumarate Inhalation, powder for 12 microgram Current Limited Availability Manufacturing 5/02/2026 glimepiride Tablet, uncoated 1 mg Current Unavailable Manufacturing 4/02/2026 glimepiride Tablet, uncoated 2 mg Current Unavailable Manufacturing 4/02/2026 clindamycin phosphate Injection, solution 0 QS Current Limited Availability Manufacturing 4/02/2026 bromocriptine mesilate Tablet, uncoated 2.87 mg Current Limited Availability Manufacturing 4/02/2026 isoniazid Tablet, uncoated 100 mg Resolved Available Manufacturing 4/02/2026 olanzapine Tablet, film coated 5 mg Current Unavailable Manufacturing 4/02/2026 amisulpride Tablet 200 mg Anticipated Available Manufacturing 4/02/2026 galantamine hydrobromide Capsule, modified release 30.768 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 4/02/2026 lamivudine Tablet, film coated 100 mg Resolved Available Manufacturing 4/02/2026 clevidipine Injection, emulsion 25 mg Anticipated Available Transport / Logistic issues / Storage capacity issues 4/02/2026 gabapentin Capsule, hard 300 mg Current Limited Availability Manufacturing 4/02/2026 fenofibrate Tablet 48 mg Current Limited Availability Manufacturing 4/02/2026 rosuvastatin calcium Tablet, film coated 41.68 mg Current Unavailable Manufacturing 4/02/2026 rosuvastatin calcium Tablet, film coated 10.42 mg Resolved Available Manufacturing 4/02/2026 pregabalin Capsule, hard 150 mg Current Unavailable Unexpected increase in consumer demand 4/02/2026 pregabalin Capsule, hard 75 mg Resolved Available Manufacturing 4/02/2026 pregabalin Capsule, hard 300 mg Resolved Available Manufacturing 4/02/2026 atomoxetine hydrochloride Capsule, hard 20.57 mg Current Unavailable Manufacturing 4/02/2026 bazedoxifene acetate~conjugated estrogens Tablet, modified release 22.56 mg~.45 mg Current Unavailable Commercial Changes / Commercial viability 4/02/2026 atorvastatin calcium trihydrate Tablet, film coated 43.38 mg Current Limited Availability Manufacturing 4/02/2026 erenumab Injection, solution 70 mg Resolved Available Unexpected increase in consumer demand 4/02/2026 dabigatran etexilate mesilate Capsule, hard 126.83 mg Current Limited Availability Manufacturing 4/02/2026 posaconazole Tablet, modified release 100 mg Current Limited Availability Manufacturing 4/02/2026 iopromide Injection, solution 768.86 mg/mL Resolved Available Transport / Logistic issues / Storage capacity issues 4/02/2026 progesterone Pessary 400 mg Current Emergency Supply Only Transport / Logistic issues / Storage capacity issues 4/02/2026 metoprolol succinate Tablet, modified release 23.75 mg Current Unavailable Unexpected increase in consumer demand 4/02/2026 methotrexate Tablet 2.5 mg Anticipated Available Manufacturing 4/02/2026 sumatriptan succinate Tablet, film coated 69.99 mg Current Unavailable Manufacturing 4/02/2026 naproxen Tablet 500 mg Anticipated Available Manufacturing 4/02/2026 aripiprazole monohydrate Injection, powder for 416.07 mg Current Unavailable Manufacturing 4/02/2026 olanzapine Tablet, film coated 2.5 mg Current Limited Availability Manufacturing 4/02/2026 ethinylestradiol~norethisterone Tablet, uncoated 36 microgram~500 microgram Current Limited Availability Manufacturing 4/02/2026 raloxifene hydrochloride Tablet, film coated 60 mg Anticipated Available Manufacturing 4/02/2026 olanzapine Wafer 5 mg Resolved Available Transport / Logistic issues / Storage capacity issues 4/02/2026 ampicillin Injection, powder for 500 mg Anticipated Available Unexpected increase in consumer demand 4/02/2026 lamotrigine Tablet, dispersible 100 mg Current Unavailable Manufacturing 4/02/2026 gabapentin Capsule, hard 400 mg Current Unavailable Manufacturing 3/02/2026 imipramine hydrochloride Tablet, sugar coated 10 mg Anticipated Available Manufacturing 3/02/2026 bupivacaine hydrochloride Injection, solution 5 mg/mL Resolved Available Manufacturing 3/02/2026 adenosine Injection, solution 6 mg Anticipated Available Manufacturing 3/02/2026 galantamine hydrobromide Capsule, modified release 10.256 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 3/02/2026 letrozole Tablet, film coated 2.5 mg Resolved Available Manufacturing 3/02/2026 Somatropin Injection, powder for 5 mg/mL Current Limited Availability Unexpected increase in consumer demand 3/02/2026 lamivudine Tablet, film coated 300 mg Current Unavailable Manufacturing 3/02/2026 rocuronium bromide Injection, solution 50 mg Current Limited Availability Manufacturing 3/02/2026 temozolomide Capsule, hard 140 mg Current Limited Availability Manufacturing 3/02/2026 valsartan~hydrochlorothiazide Tablet, film coated 160 mg~12.5 mg Current Limited Availability Manufacturing 3/02/2026 quetiapine fumarate Tablet, modified release 172.695 mg Anticipated Available Manufacturing 3/02/2026 quetiapine fumarate Tablet, modified release 57.565 mg Current Limited Availability Manufacturing 3/02/2026 linezolid Tablet, film coated 600 mg Resolved Available Manufacturing 3/02/2026 crisaborole Ointment 2 % w/w Anticipated Available Unexpected increase in consumer demand 3/02/2026 doxepin hydrochloride Capsule, hard 11.3 mg Current Unavailable Manufacturing 3/02/2026 deferasirox Tablet, film coated 90 mg Current Limited Availability Manufacturing 3/02/2026 deferasirox Tablet, film coated 360 mg Current Unavailable Manufacturing 3/02/2026 escitalopram oxalate Tablet, film coated 25.548 mg Resolved Available Manufacturing 3/02/2026 enoxaparin sodium Injection, solution 100 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 3/02/2026 rimegepant sulfate Tablet, orally disintegrating 85.65 mg Resolved Available Manufacturing 3/02/2026 daunorubicin hydrochloride Injection, powder for 20 mg Anticipated Available Manufacturing 3/02/2026 tamoxifen citrate Tablet, uncoated 15.2 mg Current Unavailable Manufacturing 3/02/2026 tamoxifen citrate Tablet, uncoated 30.4 mg Current Unavailable Manufacturing 3/02/2026 vancomycin hydrochloride Injection, powder for 1000 mg Anticipated Available Manufacturing 3/02/2026 gramicidin~framycetin sulfate~dexamethasone Ear Drops .05 mg/mL~5 mg/mL~.5 mg/mL Current Limited Availability Manufacturing 3/02/2026 levodopa~carbidopa monohydrate Tablet, uncoated 100 mg~26.9 mg Current Limited Availability Manufacturing 3/02/2026 parecoxib sodium Injection, powder for 42.36 mg Current Limited Availability Manufacturing 3/02/2026 nizatidine Capsule 300 mg Current Limited Availability Manufacturing 3/02/2026 lamotrigine Tablet, dispersible 200 mg Current Unavailable Manufacturing 3/02/2026 oxycodone hydrochloride Tablet, uncoated 5 mg Current Limited Availability Manufacturing 2/02/2026 phenylephrine hydrochloride~prednisolone acetate Eye Drops, suspension 1.2 mg/mL~10 mg/mL Current Limited Availability Unexpected increase in consumer demand 2/02/2026 methylphenidate hydrochloride Capsule, modified release 60 mg Current Limited Availability Manufacturing 2/02/2026 ibuprofen Injection, solution 5 mg/mL Current Unavailable Unexpected increase in consumer demand 2/02/2026 betahistine dihydrochloride Tablet, uncoated 16 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 2/02/2026 oseltamivir phosphate Capsule, hard 98.5 mg Resolved Available Unexpected increase in consumer demand 2/02/2026 gliclazide Tablet, uncoated 80 mg Anticipated Available Manufacturing 2/02/2026 escitalopram oxalate Tablet, film coated 12.774 mg Anticipated Available Manufacturing 2/02/2026 ondansetron hydrochloride dihydrate Tablet, film coated 4.986 mg Resolved Available Manufacturing 2/02/2026 lamotrigine Tablet 100 mg Current Unavailable Manufacturing 2/02/2026 labetalol hydrochloride Tablet, film coated 200 mg Anticipated Available Manufacturing 2/02/2026 methylphenidate hydrochloride Capsule, modified release 40 mg Current Limited Availability Manufacturing 2/02/2026 simvastatin Tablet, film coated 5 mg Current Unavailable Manufacturing 2/02/2026 - 2026.02.02
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated rifabutin Capsule, hard 150 mg Anticipated Available Manufacturing 1/02/2026 zolpidem tartrate Tablet, film coated 10 mg Anticipated Available Manufacturing 30/01/2026 calcitonin salmon Injection, solution 100 IU/mL Anticipated Available Unexpected increase in consumer demand 30/01/2026 topiramate Tablet, film coated 25 mg Anticipated Available Manufacturing 30/01/2026 moclobemide Tablet, film coated 300 mg Anticipated Available Manufacturing 30/01/2026 clevidipine Injection, emulsion 25 mg Anticipated Available Transport / Logistic issues / Storage capacity issues 30/01/2026 gabapentin Capsule, hard 300 mg Current Limited Availability Manufacturing 30/01/2026 levetiracetam Injection, intravenous infusion 100 mg/mL Anticipated Available Manufacturing 30/01/2026 pramipexole dihydrochloride monohydrate Tablet, modified release .75 mg Anticipated Available Manufacturing 30/01/2026 avanafil Tablet, uncoated 200 mg Current Limited Availability Unexpected increase in consumer demand 30/01/2026 telmisartan~amlodipine besilate Tablet, film coated 40 mg~13.87 mg Current Limited Availability Unexpected increase in consumer demand 30/01/2026 telmisartan~amlodipine besilate Tablet, film coated 40 mg~6.935 mg Current Limited Availability Unexpected increase in consumer demand 30/01/2026 quetiapine fumarate Tablet, modified release 345 mg Anticipated Available Unexpected increase in consumer demand 30/01/2026 lamotrigine Tablet, chewable 50 mg Anticipated Available Manufacturing 30/01/2026 daunorubicin hydrochloride Injection, powder for 20 mg Anticipated Available Manufacturing 30/01/2026 Interferon gamma1b Injection, solution 4 million IU/mL Discontinued Unavailable Commercial Changes / Commercial viability 30/01/2026 norethisterone~ethinylestradiol Tablet, uncoated 500 microgram~36 microgram Current Limited Availability Manufacturing 30/01/2026 rifampicin Oral Liquid 20 mg/mL Resolved Available Unexpected increase in consumer demand 29/01/2026 atracurium besilate Injection, intravenous infusion 10 mg/mL Resolved Available Manufacturing 29/01/2026 calcium polystyrene sulfonate Powder 999.3 mg/g Resolved Available Manufacturing 29/01/2026 lidocaine Spray, solution 100 mg/mL Current Unavailable Manufacturing 29/01/2026 dantrolene sodium hemiheptahydrate Injection, powder for 20 mg Resolved Available Manufacturing 29/01/2026 benzathine benzylpenicillin tetrahydrate Injection, suspension 1200000 USP Unit Current Limited Availability Manufacturing 29/01/2026 lamotrigine Tablet, chewable 200 mg Current Limited Availability Manufacturing 29/01/2026 pramipexole dihydrochloride monohydrate Tablet .125 mg Current Limited Availability Manufacturing 29/01/2026 pramipexole dihydrochloride monohydrate Tablet .25 mg Current Limited Availability Manufacturing 29/01/2026 pramipexole dihydrochloride monohydrate Tablet .25 mg Current Unavailable Manufacturing 29/01/2026 pramipexole dihydrochloride monohydrate Tablet .125 mg Current Unavailable Manufacturing 29/01/2026 montelukast sodium Tablet, chewable 4.16 mg Resolved Available Manufacturing 29/01/2026 isotretinoin Capsule, soft 10 mg Current Unavailable Manufacturing 29/01/2026 isotretinoin Capsule, soft 20 mg Current Unavailable Manufacturing 29/01/2026 phenobarbital Tablet, uncoated 30 mg Current Unavailable Manufacturing 29/01/2026 temozolomide Capsule, hard 20 mg Current Limited Availability Manufacturing 29/01/2026 ezetimibe~simvastatin Tablet 10 mg~40 mg Current Limited Availability Manufacturing 29/01/2026 midazolam Injection, solution 50 mg Current Unavailable Manufacturing 29/01/2026 propofol Injection, emulsion 10 mg/mL Resolved Available Transport / Logistic issues / Storage capacity issues 29/01/2026 pramipexole dihydrochloride monohydrate Tablet .25 mg Current Unavailable Unexpected increase in consumer demand 29/01/2026 pramipexole dihydrochloride monohydrate Tablet 1 mg Current Unavailable Manufacturing 29/01/2026 rifampicin Capsule 150 mg Current Emergency Supply Only Manufacturing 29/01/2026 pregabalin Capsule, hard 25 mg Current Unavailable Manufacturing 29/01/2026 isotretinoin Capsule, soft 10 mg Current Limited Availability Manufacturing 29/01/2026 isotretinoin Capsule, soft 20 mg Current Limited Availability Manufacturing 29/01/2026 quetiapine fumarate Tablet, modified release 57.5 mg Resolved Available Unexpected increase in consumer demand 29/01/2026 quetiapine fumarate Tablet, modified release 172.5 mg Anticipated Available Unexpected increase in consumer demand 29/01/2026 ezetimibe Tablet, uncoated 10 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 29/01/2026 codeine phosphate hemihydrate Oral Liquid 5 mg/mL Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 29/01/2026 tranexamic acid Tablet, film coated 500 mg Current Unavailable Manufacturing 29/01/2026 cyproterone acetate Tablet, uncoated 100 mg Current Limited Availability Manufacturing 29/01/2026 olmesartan medoxomil~hydrochlorothiazide Tablet 40 mg~12.5 mg Current Unavailable Manufacturing 29/01/2026 cinacalcet hydrochloride Tablet, film coated 99 mg Current Unavailable Manufacturing 29/01/2026 dabigatran etexilate mesilate Capsule, hard 172.95 mg Current Unavailable Manufacturing 29/01/2026 teriflunomide Tablet, film coated 14 mg Current Unavailable Manufacturing 29/01/2026 dimethyl fumarate Capsule, enteric 240 mg Current Unavailable Manufacturing 29/01/2026 aprepitant Capsule, hard 165 mg Anticipated Available Manufacturing 29/01/2026 tamoxifen citrate Tablet 30.34 mg Anticipated Available Manufacturing 29/01/2026 metformin hydrochloride Tablet, modified release 1000 mg Current Limited Availability Manufacturing 29/01/2026 isotretinoin Capsule, soft 10 mg Current Unavailable Manufacturing 29/01/2026 isotretinoin Capsule, soft 20 mg Current Limited Availability Manufacturing 29/01/2026 lacosamide Tablet, film coated 100 mg Current Unavailable Manufacturing 29/01/2026 temozolomide Capsule, hard 5 mg Current Limited Availability Manufacturing 29/01/2026 lanreotide acetate Injection, solution 133.33 mg Current Unavailable Manufacturing 29/01/2026 sodium nitroprusside Injection, concentrated 50 mg Current Unavailable Commercial Changes / Commercial viability 29/01/2026 isotretinoin Capsule, soft 20 mg Current Unavailable Manufacturing 29/01/2026 isotretinoin Capsule, soft 10 mg Current Unavailable Manufacturing 29/01/2026 lidocaine hydrochloride Injection, solution 10 mg/mL Anticipated Available Manufacturing 29/01/2026 nizatidine Capsule, hard 300 mg Current Limited Availability Manufacturing 29/01/2026 chlorhexidine gluconate Solution, irrigation 30 mg Current Limited Availability Manufacturing 28/01/2026 leflunomide Tablet, film coated 10 mg Anticipated Available Manufacturing 28/01/2026 fluorouracil Injection, solution 5000 mg Current Unavailable Unexpected increase in consumer demand 28/01/2026 pioglitazone hydrochloride Tablet 49.9 mg Anticipated Available Manufacturing 28/01/2026 clopidogrel hydrogen sulfate Tablet, film coated 97.875 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 28/01/2026 rosuvastatin calcium Tablet, film coated 41.68 mg Current Unavailable Manufacturing 28/01/2026 rosuvastatin calcium Tablet, film coated 10.42 mg Current Unavailable Manufacturing 28/01/2026 rosuvastatin calcium Tablet, film coated 20.84 mg Current Unavailable Unexpected increase in consumer demand 28/01/2026 pregabalin Capsule, hard 150 mg Current Limited Availability Unexpected increase in consumer demand 28/01/2026 carbidopa monohydrate~entacapone~levodopa Tablet, film coated 27 mg~200 mg~100 mg Resolved Available Unexpected increase in consumer demand 28/01/2026 ondansetron Tablet, orally disintegrating 4 mg Current Limited Availability Manufacturing 28/01/2026 teriflunomide Tablet, film coated 14 mg Current Limited Availability Manufacturing 28/01/2026 montelukast sodium Tablet, chewable 4.16 mg Current Unavailable Manufacturing 28/01/2026 montelukast sodium Tablet, film coated 10.4 mg Current Limited Availability Manufacturing 28/01/2026 finasteride Tablet, film coated 1 mg Resolved Available Manufacturing 28/01/2026 lamotrigine Tablet, chewable 50 mg Anticipated Available Manufacturing 28/01/2026 flecainide acetate Tablet 50 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 28/01/2026 sodium chloride Injection, solution 90 mg Resolved Available Manufacturing 28/01/2026 lidocaine hydrochloride monohydrate Injection, solution 10 mg/mL Resolved Available Manufacturing 28/01/2026 levodopa~carbidopa monohydrate Tablet, uncoated 100 mg~26.9 mg Current Limited Availability Manufacturing 28/01/2026 carbidopa monohydrate~entacapone~levodopa Tablet, film coated 27 mg~200 mg~100 mg Resolved Available Manufacturing 28/01/2026 salbutamol sulfate Inhalation, conventional 6 mg Current Unavailable Manufacturing 27/01/2026 salbutamol sulfate Inhalation 2.4 mg/mL Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 27/01/2026 tranexamic acid Tablet, film coated 500 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 27/01/2026 oxycodone hydrochloride Tablet, uncoated 5 mg Anticipated Available Manufacturing 27/01/2026 mesalazine Suppository, moulded 1000 mg Current Limited Availability Manufacturing 27/01/2026 tranexamic acid Tablet, film coated 500 mg Current Unavailable Manufacturing 27/01/2026 trientine dihydrochloride Capsule 250 mg Discontinued Reduction in supply until supply is exhausted Manufacturing 27/01/2026 progesterone Pessary 400 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 27/01/2026 olipudase alfa Injection, powder for 20 mg Anticipated Available Manufacturing 27/01/2026 dantrolene sodium hemiheptahydrate Capsule 25 mg Current Unavailable Manufacturing 27/01/2026 dantrolene sodium hemiheptahydrate Capsule 50 mg Current Unavailable Manufacturing 27/01/2026 mefloquine hydrochloride Tablet, uncoated 274.09 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 27/01/2026 - 2026.01.26
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated calcitonin salmon Injection, solution 100 IU/mL Anticipated Available Unexpected increase in consumer demand 23/01/2026 lamotrigine Tablet, chewable 25 mg Anticipated Available Manufacturing 23/01/2026 lamotrigine Tablet, chewable 200 mg Anticipated Available Manufacturing 23/01/2026 cyproterone acetate Tablet, uncoated 50 mg Resolved Available Manufacturing 23/01/2026 aripiprazole Tablet, uncoated 10 mg Current Limited Availability Manufacturing 23/01/2026 mirtazapine Tablet, film coated 15 mg Current Limited Availability Manufacturing 23/01/2026 quetiapine fumarate Tablet, modified release 172.695 mg Anticipated Available Manufacturing 23/01/2026 elotuzumab Injection, powder for 340 mg Anticipated Available Manufacturing 23/01/2026 trientine dihydrochloride Capsule 250 mg Discontinued Reduction in supply until supply is exhausted Manufacturing 23/01/2026 lamotrigine Tablet, chewable 25 mg Anticipated Available Manufacturing 23/01/2026 lamotrigine Tablet, chewable 200 mg Current Unavailable Manufacturing 23/01/2026 rosuvastatin calcium Tablet, film coated 20.84 mg Anticipated Available Manufacturing 23/01/2026 tirzepatide Injection, solution 5 mg Discontinued Unavailable Commercial Changes / Commercial viability 23/01/2026 tirzepatide Injection, solution 7.5 mg Discontinued Unavailable Commercial Changes / Commercial viability 23/01/2026 tirzepatide Injection, solution 12.5 mg Discontinued Unavailable Commercial Changes / Commercial viability 23/01/2026 tirzepatide Injection, solution 10 mg Discontinued Unavailable Commercial Changes / Commercial viability 23/01/2026 tirzepatide Injection, solution 15 mg Discontinued Unavailable Commercial Changes / Commercial viability 23/01/2026 tirzepatide Injection, solution 2.5 mg Discontinued Unavailable Commercial Changes / Commercial viability 23/01/2026 clindamycin phosphate Cream 22.8 mg/g Anticipated Available Unexpected increase in consumer demand 23/01/2026 gliclazide Tablet, uncoated 80 mg Anticipated Available Manufacturing 23/01/2026 methylphenidate hydrochloride Capsule, modified release 20 mg Resolved Available Manufacturing 23/01/2026 digoxin Injection, solution .25 mg/mL Resolved Available Manufacturing 22/01/2026 codeine phosphate hemihydrate Oral Liquid, solution 5 mg/mL Current Unavailable Manufacturing 22/01/2026 lidocaine Spray, solution 100 mg/mL Anticipated Available Manufacturing 22/01/2026 ciprofloxacin hydrochloride Tablet, film coated 832.5 mg Current Unavailable Manufacturing 22/01/2026 olanzapine pamoate monohydrate Injection, powder for 690 mg Resolved Available Transport / Logistic issues / Storage capacity issues 22/01/2026 nortriptyline Tablet, film coated 10 mg Current Limited Availability Manufacturing 22/01/2026 aripiprazole Tablet, uncoated 10 mg Resolved Available Manufacturing 22/01/2026 galantamine hydrobromide Capsule, modified release 20.512 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 22/01/2026 pramipexole dihydrochloride monohydrate Tablet 1 mg Resolved Available Manufacturing 22/01/2026 ondansetron hydrochloride dihydrate Tablet, film coated 9.972 mg Resolved Available Manufacturing 22/01/2026 metronidazole Tablet, uncoated 400 mg Current Unavailable Manufacturing 22/01/2026 mirtazapine Tablet, orally disintegrating 15 mg Anticipated Available Manufacturing 22/01/2026 montelukast sodium Tablet, chewable 4.16 mg Resolved Available Manufacturing 22/01/2026 montelukast sodium Tablet 10.4 mg Anticipated Available Commercial Changes / Commercial viability 22/01/2026 quetiapine fumarate Tablet, modified release 172.695 mg Current Limited Availability Manufacturing 22/01/2026 candesartan cilexetil~hydrochlorothiazide Tablet, uncoated 16 mg~12.5 mg Anticipated Available Manufacturing 22/01/2026 ezetimibe Tablet, uncoated 10 mg Current Unavailable Unexpected increase in consumer demand 22/01/2026 codeine phosphate hemihydrate Oral Liquid 5 mg/mL Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 22/01/2026 hydrochlorothiazide~olmesartan medoxomil Tablet 12.5 mg~40 mg Current Unavailable Manufacturing 22/01/2026 ondansetron hydrochloride dihydrate Tablet, film coated 9.972 mg Resolved Available Manufacturing 22/01/2026 amlodipine besilate~olmesartan medoxomil Tablet, film coated 6.935 mg~20 mg Current Limited Availability Manufacturing 22/01/2026 amlodipine besilate~olmesartan medoxomil Tablet, film coated 6.935 mg~40 mg Current Limited Availability Manufacturing 22/01/2026 lacosamide Tablet, film coated 50 mg Anticipated Available Manufacturing 22/01/2026 doxepin hydrochloride Capsule, hard 11.3 mg Current Unavailable Manufacturing 22/01/2026 aprepitant Capsule, hard 165 mg Anticipated Available Manufacturing 22/01/2026 gliclazide Tablet, uncoated 80 mg Anticipated Available Manufacturing 22/01/2026 nitrofurantoin Capsule, hard 50 mg Anticipated Available Unexpected increase in consumer demand 22/01/2026 nitrofurantoin Capsule, hard 100 mg Current Limited Availability Unexpected increase in consumer demand 22/01/2026 nitrofurantoin Capsule, hard 100 mg Current Unavailable Unexpected increase in consumer demand 22/01/2026 atracurium besilate Injection, solution 10 mg/mL Resolved Available Manufacturing 22/01/2026 olanzapine Tablet, film coated 5 mg Resolved Available Transport / Logistic issues / Storage capacity issues 22/01/2026 doxepin hydrochloride Capsule, hard 28.25 mg Current Unavailable Manufacturing 22/01/2026 naratriptan hydrochloride Tablet, film coated 2.78 mg Current Unavailable Manufacturing 22/01/2026 ziprasidone hydrochloride monohydrate Capsule, hard 22.65 mg Anticipated Available Manufacturing 22/01/2026 desferrioxamine mesilate Injection, powder for 2 g Current Limited Availability Manufacturing 22/01/2026 ciprofloxacin hydrochloride Tablet, film coated 873.32 mg Resolved Available Manufacturing 22/01/2026 ciprofloxacin hydrochloride Tablet, film coated 582.21 mg Current Limited Availability Manufacturing 22/01/2026 parecoxib sodium Injection, powder for 42.36 mg Anticipated Available Manufacturing 22/01/2026 lamotrigine Tablet, dispersible 200 mg Current Unavailable Manufacturing 22/01/2026 Coxiella burnetii Injection 50 microgram/mL Current Limited Availability Manufacturing 21/01/2026 lidocaine hydrochloride Gel 20 mg/g Anticipated Available Manufacturing 21/01/2026 ibuprofen~codeine phosphate hemihydrate Tablet, film coated 200 mg~12.8 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 21/01/2026 Somatropin Injection, powder for 5 mg/mL Anticipated Available Unexpected increase in consumer demand 21/01/2026 phenylephrine hydrochloride~prednisolone acetate Eye Drops, suspension 1.2 mg/mL~10 mg/mL Current Limited Availability Unexpected increase in consumer demand 21/01/2026 aprepitant Capsule 165 mg Anticipated Available Manufacturing 21/01/2026 oseltamivir phosphate Capsule, hard 98.5 mg Current Unavailable Unexpected increase in consumer demand 21/01/2026 sacubitril~valsartan Tablet, film coated 48.6 mg~51.4 mg Current Unavailable Manufacturing 21/01/2026 valsartan~sacubitril Tablet, film coated 25.7 mg~24.3 mg Current Unavailable Manufacturing 21/01/2026 valsartan~sacubitril Tablet, film coated 102.8 mg~97.2 mg Current Unavailable Manufacturing 21/01/2026 flunitrazepam Tablet, film coated 1 mg Current Unavailable Manufacturing 21/01/2026 galantamine hydrobromide~galantamine Capsule, modified release 10.25 mg~8 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 21/01/2026 galantamine~galantamine hydrobromide Capsule, modified release 24 mg~30.76 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 21/01/2026 lamotrigine Tablet, chewable 50 mg Resolved Available Manufacturing 20/01/2026 tranexamic acid Injection, solution 1000 mg Discontinued Unavailable Manufacturing 20/01/2026 riluzole Tablet, film coated 50 mg Current Unavailable Manufacturing 20/01/2026 atorvastatin calcium trihydrate Tablet, film coated 21.69 mg Current Unavailable Manufacturing 20/01/2026 pramipexole dihydrochloride monohydrate Tablet .25 mg Current Unavailable Unexpected increase in consumer demand 20/01/2026 metformin hydrochloride Tablet, modified release 1000 mg Resolved Available Manufacturing 20/01/2026 rosuvastatin calcium Tablet, film coated 10.42 mg Current Unavailable Manufacturing 20/01/2026 bimatoprost Eye Drops .3 mg/mL Current Unavailable Manufacturing 20/01/2026 methylphenidate hydrochloride Capsule, modified release 60 mg Current Limited Availability Manufacturing 20/01/2026 tadalafil Tablet 10 mg Discontinued Reduction in supply until supply is exhausted Manufacturing 20/01/2026 temozolomide Capsule, hard 5 mg Anticipated Available Manufacturing 20/01/2026 methylphenidate hydrochloride Capsule, modified release 40 mg Current Limited Availability Manufacturing 20/01/2026 rifampicin Oral Liquid 20 mg/mL Anticipated Available Unexpected increase in consumer demand 19/01/2026 lidocaine hydrochloride Injection, concentrated 100 mg/mL Anticipated Available Manufacturing 19/01/2026 topiramate Tablet, film coated 25 mg Resolved Available Manufacturing 19/01/2026 risperidone Tablet 1 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 19/01/2026 calcium folinate hydrate Tablet, uncoated 18.6 mg Resolved Available Unexpected increase in consumer demand 19/01/2026 levetiracetam Tablet, film coated 500 mg Resolved Available Manufacturing 19/01/2026 pramipexole dihydrochloride monohydrate Tablet .125 mg Current Unavailable Manufacturing 19/01/2026 sildenafil citrate Tablet, film coated 140.45 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 19/01/2026 ondansetron hydrochloride dihydrate Tablet, film coated 4.986 mg Resolved Available Manufacturing 19/01/2026 indapamide hemihydrate Tablet, sugar coated 2.5 mg Current Unavailable Manufacturing 19/01/2026 montelukast sodium Tablet, chewable 4.16 mg Current Unavailable Manufacturing 19/01/2026 ambrisentan Tablet, film coated 10 mg Resolved Available Manufacturing 19/01/2026 moxonidine Tablet, film coated 400 microgram Current Limited Availability Commercial Changes / Commercial viability 19/01/2026 moxonidine Tablet, film coated 200 microgram Current Unavailable Commercial Changes / Commercial viability 19/01/2026 rasagiline mesilate Tablet 1.56 mg Current Unavailable Manufacturing 19/01/2026 eplerenone Tablet, film coated 50 mg Resolved Available Manufacturing 19/01/2026 eplerenone Tablet, film coated 25 mg Resolved Available Manufacturing 19/01/2026 levothyroxine sodium Tablet .075 mg Current Limited Availability Manufacturing 19/01/2026 - 2026.01.19
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated topiramate Tablet, film coated 25 mg Resolved Available Manufacturing 19/01/2026 lamotrigine Tablet, chewable 200 mg Anticipated Available Manufacturing 19/01/2026 levetiracetam Tablet, film coated 500 mg Resolved Available Manufacturing 19/01/2026 pramipexole dihydrochloride monohydrate Tablet 1 mg Current Unavailable Manufacturing 19/01/2026 ondansetron hydrochloride dihydrate Tablet, film coated 4.986 mg Resolved Available Manufacturing 19/01/2026 montelukast sodium Tablet, chewable 4.16 mg Current Unavailable Manufacturing 19/01/2026 eplerenone Tablet, film coated 50 mg Resolved Available Manufacturing 19/01/2026 eplerenone Tablet, film coated 25 mg Resolved Available Manufacturing 19/01/2026 aprepitant Capsule 165 mg Current Limited Availability Manufacturing 19/01/2026 lamotrigine Tablet, chewable 50 mg Resolved Available Manufacturing 19/01/2026 ciprofloxacin hydrochloride Tablet, film coated 873.32 mg Current Unavailable Manufacturing 19/01/2026 terbinafine hydrochloride Tablet, uncoated 281.25 mg Current Unavailable Manufacturing 16/01/2026 salbutamol sulfate Inhalation 2.4 mg/mL Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 16/01/2026 donepezil hydrochloride Tablet, film coated 5 mg Resolved Available Manufacturing 16/01/2026 tacrolimus monohydrate Capsule, hard 5.112 mg Resolved Available Manufacturing 16/01/2026 olanzapine Tablet, orally disintegrating 5 mg Resolved Available Manufacturing 16/01/2026 valsartan~hydrochlorothiazide Tablet, film coated 160 mg~12.5 mg Current Limited Availability Manufacturing 16/01/2026 temozolomide Capsule, hard 20 mg Current Unavailable Manufacturing 16/01/2026 entecavir Tablet, film coated 1 mg Current Unavailable Manufacturing 16/01/2026 fenofibrate Tablet 48 mg Anticipated Available Manufacturing 16/01/2026 tobramycin Inhalation, conventional 60 mg/mL Resolved Available Manufacturing 16/01/2026 fingolimod hydrochloride Capsule 560 microgram Current Unavailable Manufacturing 16/01/2026 pentamidine isetionate Injection, powder for 300 mg Resolved Available Manufacturing 16/01/2026 ketorolac trometamol Injection, solution 10 mg/mL Current Unavailable Manufacturing 16/01/2026 lanreotide acetate Injection, solution 100 mg Current Unavailable Manufacturing 16/01/2026 lanreotide acetate Injection, solution 66.67 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 16/01/2026 nitrofurantoin Capsule, hard 100 mg Current Unavailable Unexpected increase in consumer demand 16/01/2026 nitrofurantoin Capsule, hard 50 mg Current Limited Availability Manufacturing 16/01/2026 hydrocortisone hydrogen succinate Injection, powder for 127.6 mg Resolved Available Manufacturing 16/01/2026 amphotericin B Injection, powder for 50 mg Resolved Available Manufacturing 16/01/2026 tetrabenazine Tablet, uncoated 25 mg Resolved Available Manufacturing 16/01/2026 olipudase alfa Injection, powder for 20 mg Anticipated Available Manufacturing 16/01/2026 olanzapine Tablet, film coated 5 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 16/01/2026 atovaquone~proguanil hydrochloride Tablet, film coated 62.5 mg~25 mg Anticipated Available Unexpected increase in consumer demand 16/01/2026 flumetasone pivalate~clioquinol Ear Drops .2 mg/mL~10 mg/mL Anticipated Available Commercial Changes / Commercial viability 15/01/2026 bupivacaine hydrochloride Injection, solution 5 mg/mL Current Unavailable Manufacturing 15/01/2026 propofol Injection, intravenous infusion 10 mg/mL Anticipated Available Transport / Logistic issues / Storage capacity issues 15/01/2026 galantamine hydrobromide Capsule, modified release 10.256 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 15/01/2026 temozolomide Capsule, hard 140 mg Anticipated Available Manufacturing 15/01/2026 lansoprazole Tablet, orally disintegrating 15 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 15/01/2026 amlodipine besilate~telmisartan Tablet, film coated 13.87 mg~40 mg Current Limited Availability Unexpected increase in consumer demand 15/01/2026 telmisartan~amlodipine besilate Tablet, film coated 80 mg~6.935 mg Current Limited Availability Unexpected increase in consumer demand 15/01/2026 telmisartan~amlodipine besilate Tablet, film coated 80 mg~13.87 mg Current Limited Availability Unexpected increase in consumer demand 15/01/2026 amlodipine besilate~telmisartan Tablet, film coated 6.935 mg~40 mg Current Limited Availability Unexpected increase in consumer demand 15/01/2026 isotretinoin Capsule, soft 20 mg Current Limited Availability Manufacturing 15/01/2026 betahistine dihydrochloride Tablet 16 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 15/01/2026 moxonidine Tablet, film coated 400 microgram Current Unavailable Manufacturing 15/01/2026 agomelatinecitric acid Tablet, film coated 44.739 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 15/01/2026 iopromide Injection, solution 768.86 mg/mL Current Unavailable Transport / Logistic issues / Storage capacity issues 15/01/2026 paroxetine hydrochloride Tablet, film coated 22.22 mg Resolved Available Manufacturing 15/01/2026 levothyroxine sodium Tablet, uncoated .1 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 15/01/2026 tranexamic acid Tablet, film coated 500 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 15/01/2026 isotretinoin Capsule, soft 20 mg Current Unavailable Manufacturing 15/01/2026 framycetin sulfate Eye and Ear Drops 5 mg/mL Current Limited Availability Manufacturing 15/01/2026 estradiol hemihydrate Drug delivery system, transdermal 3.09 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 15/01/2026 dinoprostone Gel .3333 mg/g Current Unavailable Manufacturing 15/01/2026 ambrisentan Tablet, film coated 5 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 14/01/2026 olanzapine Tablet, film coated 5 mg Current Unavailable Manufacturing 14/01/2026 calcium folinate hydrate Tablet, uncoated 18.6 mg Current Limited Availability Unexpected increase in consumer demand 14/01/2026 carbidopa monohydrate~levodopa~entacapone Tablet, film coated 40.5 mg~150 mg~200 mg Resolved Available Unexpected increase in consumer demand 14/01/2026 teriflunomide Tablet, film coated 14 mg Current Unavailable Manufacturing 14/01/2026 posaconazole Tablet, modified release 100 mg Current Limited Availability Manufacturing 14/01/2026 sitagliptin hydrochloride monohydrate~metformin hydrochloride Tablet, modified release 56.685 mg~1000 mg Resolved Available Manufacturing 14/01/2026 prilocaine hydrochloride Injection, solution 100 mg Resolved Available Transport / Logistic issues / Storage capacity issues 14/01/2026 varenicline tartrate~varenicline tartrate Tablet, film coated .855 mg~1.71 mg Resolved Available Manufacturing 14/01/2026 metformin hydrochloride Tablet, modified release 1000 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 14/01/2026 cytarabine Injection, solution 100 mg/mL Anticipated Available Manufacturing 14/01/2026 desferrioxamine mesilate Injection, powder for 2 g Current Limited Availability Manufacturing 14/01/2026 betiatide Injection, powder for 1 mg Current Unavailable Manufacturing 13/01/2026 acetylcysteine Injection, concentrated 2 g Current Limited Availability Manufacturing 13/01/2026 verapamil hydrochloride Tablet, film coated 240 mg Resolved Available Manufacturing 13/01/2026 venlafaxine Capsule, modified release 75 mg Current Unavailable Manufacturing 13/01/2026 ondansetron hydrochloride dihydrate Injection, solution 5 mg Current Unavailable Manufacturing 13/01/2026 ondansetron hydrochloride dihydrate Injection, solution 10 mg Current Limited Availability Manufacturing 13/01/2026 mycophenolate mofetil Tablet, film coated 500 mg Resolved Available Manufacturing 13/01/2026 remifentanil hydrochloride Injection, powder for 1.097 mg Resolved Available Manufacturing 13/01/2026 temozolomide Capsule, hard 5 mg Current Limited Availability Manufacturing 13/01/2026 lansoprazole Tablet, orally disintegrating 30 mg Current Limited Availability Manufacturing 13/01/2026 lansoprazole Tablet, orally disintegrating 15 mg Current Limited Availability Commercial Changes / Commercial viability 13/01/2026 propofol Injection, emulsion 10 mg/mL Current Unavailable Transport / Logistic issues / Storage capacity issues 13/01/2026 fentanyl citrate Injection, solution 785 microgram Discontinued Unavailable Commercial Changes / Commercial viability 13/01/2026 pramipexole dihydrochloride monohydrate Tablet .125 mg Resolved Available Unexpected increase in consumer demand 13/01/2026 atomoxetine hydrochloride Capsule, hard 20.57 mg Current Unavailable Manufacturing 13/01/2026 paracetamol Injection .5 g Discontinued Unavailable Commercial Changes / Commercial viability 13/01/2026 paracetamol Injection .1 g Discontinued Unavailable Commercial Changes / Commercial viability 13/01/2026 atorvastatin calcium trihydrate Tablet, film coated 43.38 mg Current Limited Availability Manufacturing 13/01/2026 doxepin hydrochloride Capsule, hard 11.3 mg Current Unavailable Manufacturing 13/01/2026 erlotinib hydrochloride Tablet, film coated 27.32 mg Current Unavailable Unexpected increase in consumer demand 13/01/2026 atorvastatin calcium trihydrate Tablet, film coated 86.751 mg Resolved Available Manufacturing 13/01/2026 prucalopride succinate Tablet 1.321 mg Current Unavailable Manufacturing 13/01/2026 prucalopride succinate Tablet 2.642 mg Current Unavailable Manufacturing 13/01/2026 Teriparatide Injection, solution 250 microgram/mL Resolved Available Manufacturing 13/01/2026 doxepin hydrochloride Capsule, hard 28.25 mg Current Limited Availability Manufacturing 13/01/2026 flunitrazepam Tablet, film coated 1 mg Current Unavailable Manufacturing 13/01/2026 bupivacaine hydrochloride monohydrate Injection, solution 52.8 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 12/01/2026 calcitonin salmon Injection, solution 100 IU/mL Anticipated Available Unexpected increase in consumer demand 12/01/2026 dantrolene sodium hemiheptahydrate Injection, powder for 20 mg Current Emergency Supply Only Manufacturing 12/01/2026 trimethoprim~sulfamethoxazole Injection, concentrated 16 mg/mL~80 mg/mL Current Unavailable Manufacturing 12/01/2026 midazolam hydrochloride Injection, solution 5.56 mg/mL Discontinued Unavailable Commercial Changes / Commercial viability 12/01/2026 tranexamic acid Tablet, film coated 500 mg Current Unavailable Manufacturing 12/01/2026 erenumab Injection, solution 70 mg Current Limited Availability Unexpected increase in consumer demand 12/01/2026 ambrisentan Tablet, film coated 5 mg Resolved Available Manufacturing 12/01/2026 ambrisentan Tablet, film coated 10 mg Resolved Available Manufacturing 12/01/2026 estradiol Drug delivery system, transdermal .39 mg Current Unavailable Manufacturing 12/01/2026 estradiol Drug delivery system, transdermal .78 mg Current Unavailable Manufacturing 12/01/2026 estradiol Drug delivery system, transdermal 1.17 mg Current Unavailable Manufacturing 12/01/2026 estradiol Drug delivery system, transdermal 1.56 mg Current Unavailable Manufacturing 12/01/2026 Teriparatide Injection, solution .25 mg/mL Anticipated Available Manufacturing 12/01/2026 clindamycin phosphate Cream 22.8 mg/g Anticipated Available Unexpected increase in consumer demand 12/01/2026 Peginterferon alfa2a Injection, solution 135 microgram Current Unavailable Manufacturing 12/01/2026 Peginterferon alfa2a Injection, solution 180 microgram Current Unavailable Manufacturing 12/01/2026 dinoprostone Gel .6667 mg/g Current Unavailable Manufacturing 12/01/2026 - 2026.01.12
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated lidocaine hydrochloride Injection, concentrated 100 mg/mL Anticipated Available Manufacturing 9/01/2026 trandolapril Capsule 4 mg Current Limited Availability Manufacturing 9/01/2026 isoniazid Tablet, uncoated 100 mg Anticipated Available Manufacturing 9/01/2026 montelukast sodium Tablet, chewable 5.2 mg Anticipated Available Manufacturing 9/01/2026 valsartan~hydrochlorothiazide Tablet, film coated 160 mg~12.5 mg Anticipated Available Manufacturing 9/01/2026 temozolomide Capsule, hard 20 mg Anticipated Available Manufacturing 9/01/2026 simvastatin~ezetimibe Tablet 40 mg~10 mg Anticipated Available Manufacturing 9/01/2026 raloxifene hydrochloride Tablet, film coated 60 mg Anticipated Available Manufacturing 9/01/2026 clindamycin hydrochloride Capsule, hard 162.87 mg Anticipated Available Manufacturing 9/01/2026 clindamycin hydrochloride Capsule, hard 162.87 mg Anticipated Available Manufacturing 9/01/2026 dulaglutide Injection, solution 1.5 mg Resolved Available Manufacturing 9/01/2026 methylphenidate hydrochloride Capsule, modified release 60 mg Current Limited Availability Manufacturing 9/01/2026 tenofovir disoproxil fumarate~emtricitabine Tablet, film coated 300 mg~200 mg Anticipated Available Manufacturing 9/01/2026 ambrisentan Tablet, film coated 10 mg Anticipated Available Manufacturing 9/01/2026 ambrisentan Tablet, film coated 5 mg Current Limited Availability Manufacturing 9/01/2026 hydrochlorothiazide~olmesartan medoxomil Tablet 12.5 mg~40 mg Current Unavailable Manufacturing 9/01/2026 bimatoprost Eye Drops .3 mg/mL Current Limited Availability Manufacturing 9/01/2026 dabigatran etexilate mesilate Capsule, hard 172.95 mg Current Unavailable Manufacturing 9/01/2026 paroxetine hydrochloride Tablet, film coated 22.22 mg Current Unavailable Manufacturing 9/01/2026 Adalimumab Injection, solution 20 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 9/01/2026 gliclazide Tablet, uncoated 80 mg Anticipated Available Manufacturing 9/01/2026 estradiol Drug delivery system, transdermal .585 mg Current Unavailable Manufacturing 9/01/2026 lamotrigine Tablet, chewable 100 mg Resolved Available Manufacturing 9/01/2026 lamotrigine Tablet, chewable 200 mg Current Unavailable Manufacturing 9/01/2026 nitrofurantoin Capsule, hard 100 mg Resolved Available Unexpected increase in consumer demand 9/01/2026 isotretinoin Capsule, soft 10 mg Current Unavailable Manufacturing 9/01/2026 mupirocin Ointment 20 mg/g Resolved Available Manufacturing 9/01/2026 levodopa~carbidopa monohydrate Tablet, uncoated 100 mg~26.9 mg Current Limited Availability Manufacturing 9/01/2026 pioglitazone hydrochloride Tablet, uncoated 16.53 mg Current Unavailable Manufacturing 9/01/2026 pioglitazone hydrochloride Tablet, uncoated 33.06 mg Current Unavailable Manufacturing 9/01/2026 pioglitazone hydrochloride Tablet, uncoated 49.59 mg Current Unavailable Manufacturing 9/01/2026 methylphenidate hydrochloride Capsule, modified release 20 mg Current Limited Availability Manufacturing 9/01/2026 methylphenidate hydrochloride Capsule, modified release 40 mg Current Limited Availability Manufacturing 9/01/2026 rifampicin Oral Liquid 20 mg/mL Anticipated Available Unexpected increase in consumer demand 8/01/2026 baclofen Tablet, uncoated 10 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 8/01/2026 trandolapril Capsule 2 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 8/01/2026 ciprofloxacin hydrochloride Tablet, film coated 555 mg Current Limited Availability Manufacturing 8/01/2026 nortriptyline Tablet, film coated 10 mg Anticipated Available Manufacturing 8/01/2026 lamotrigine Tablet, chewable 100 mg Resolved Available Manufacturing 8/01/2026 finasteride Tablet, film coated 1 mg Anticipated Available Unexpected increase in consumer demand 8/01/2026 galantamine hydrobromide Capsule, modified release 20.512 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 8/01/2026 galantamine hydrobromide Capsule, modified release 30.768 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 8/01/2026 bisoprolol fumarate Tablet 2.5 mg Resolved Available Manufacturing 8/01/2026 bisoprolol fumarate Tablet 10 mg Resolved Available Manufacturing 8/01/2026 levetiracetam Tablet, film coated 500 mg Current Limited Availability Manufacturing 8/01/2026 rocuronium bromide Injection, solution 50 mg Current Limited Availability Manufacturing 8/01/2026 pramipexole dihydrochloride monohydrate Tablet .25 mg Current Unavailable Manufacturing 8/01/2026 pramipexole dihydrochloride monohydrate Tablet 1 mg Current Unavailable Manufacturing 8/01/2026 exemestane Tablet, sugar coated 25 mg Resolved Available Manufacturing 8/01/2026 galantamine hydrobromide Capsule, modified release 10.252 mg Current Unavailable Manufacturing 8/01/2026 galantamine hydrobromide Capsule, modified release 30.756 mg Current Unavailable Manufacturing 8/01/2026 galantamine hydrobromide Capsule, modified release 20.504 mg Current Unavailable Manufacturing 8/01/2026 mirtazapine Tablet, orally disintegrating 15 mg Anticipated Available Manufacturing 8/01/2026 montelukast sodium Tablet, chewable 5.2 mg Anticipated Available Manufacturing 8/01/2026 montelukast sodium Tablet, chewable 4.16 mg Current Unavailable Manufacturing 8/01/2026 enalapril maleate Tablet 5 mg Current Unavailable Manufacturing 8/01/2026 enalapril maleate Tablet 5 mg Resolved Available Manufacturing 8/01/2026 quetiapine fumarate Tablet, modified release 230.26 mg Resolved Available Manufacturing 8/01/2026 GluureaLys(ahx)hbedCC Injection, powder for 25 microgram Resolved Available Manufacturing 8/01/2026 GluureaLys(ahx)hbedCC Injection, powder for 25 microgram Resolved Available Manufacturing 8/01/2026 mitomycin Injection, powder for 20 mg Current Limited Availability Manufacturing 8/01/2026 isoprenaline hydrochloride Injection, solution 1 mg Discontinued Unavailable Commercial Changes / Commercial viability 8/01/2026 diltiazem hydrochloride Capsule, modified release 180 mg Current Limited Availability Manufacturing 8/01/2026 diltiazem hydrochloride Capsule, modified release 360 mg Current Limited Availability Manufacturing 8/01/2026 ciprofloxacin hydrochloride Tablet, film coated 582.21 mg Current Limited Availability Manufacturing 8/01/2026 nizatidine Capsule, hard 300 mg Resolved Available Manufacturing 8/01/2026 galantamine hydrobromide~galantamine Capsule, modified release 10.25 mg~8 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 8/01/2026 galantamine hydrobromide~galantamine Capsule, modified release 20.51 mg~16 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 8/01/2026 galantamine hydrobromide~galantamine Capsule, modified release 30.76 mg~24 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 8/01/2026 bethanechol chloride Tablet, uncoated 10 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 7/01/2026 galantamine hydrobromide Capsule, modified release 30.756 mg Current Unavailable Manufacturing 7/01/2026 cyproterone acetate Tablet, uncoated 100 mg Anticipated Available Manufacturing 7/01/2026 paclitaxel Injection, powder for 100 mg Anticipated Available Manufacturing 7/01/2026 cabazitaxel Injection, concentrated 60 mg Current Limited Availability Manufacturing 7/01/2026 rimegepant sulfate Tablet, orally disintegrating 85.65 mg Anticipated Available Manufacturing 7/01/2026 stannous chloride dihydrate Injection, powder for 19.2 microgram/mL Current Unavailable Manufacturing 7/01/2026 ropivacaine hydrochloride Injection, solution 10 mg/mL Anticipated Available Manufacturing 7/01/2026 desferrioxamine mesilate Injection, powder for 2 g Current Limited Availability Manufacturing 7/01/2026 etoposide phosphate Injection, powder for 1136 mg Current Limited Availability Manufacturing 7/01/2026 cyproterone acetate Tablet, uncoated 50 mg Resolved Available Unexpected increase in consumer demand 6/01/2026 diclofenac potassium Oral Liquid, powder for 50 mg Discontinued Unavailable Commercial Changes / Commercial viability 6/01/2026 tranexamic acid Tablet, film coated 500 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 6/01/2026 calcium folinate hydrate Tablet, uncoated 18.6 mg Anticipated Available Unexpected increase in consumer demand 6/01/2026 galantamine hydrobromide Capsule, modified release 10.252 mg Current Unavailable Manufacturing 6/01/2026 galantamine hydrobromide Capsule, modified release 20.504 mg Current Unavailable Manufacturing 6/01/2026 montelukast sodium Tablet 10.4 mg Anticipated Available Commercial Changes / Commercial viability 6/01/2026 pemetrexed disodium Injection, powder for 1102.9 mg Current Unavailable Manufacturing 6/01/2026 Pegvisomant Injection, powder for 10 mg Resolved Available Manufacturing 6/01/2026 topotecan hydrochloride Injection, concentrated 4.346 mg Current Limited Availability Unexpected increase in consumer demand 6/01/2026 clonidine hydrochloride Tablet, uncoated 150 microgram Current Unavailable Manufacturing 6/01/2026 live varicella vaccine Injection, powder for 2700 PFU/mL Resolved Available Unexpected increase in demand due to other sponsors unable to supply 5/01/2026 risperidone Tablet 1 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 5/01/2026 cyproterone acetate Tablet, uncoated 50 mg Current Limited Availability Manufacturing 5/01/2026 iopromide Injection, solution 498.72 mg/mL Resolved Available Manufacturing 5/01/2026 ropivacaine hydrochloride Injection, solution 2 mg/mL Resolved Available Unexpected increase in demand due to other sponsors unable to supply 5/01/2026 ropivacaine hydrochloride Injection, solution 7.5 mg/mL Resolved Available Unexpected increase in demand due to other sponsors unable to supply 5/01/2026 pemetrexed disodium Injection, powder for 551.4 mg Current Limited Availability Manufacturing 5/01/2026 linezolid Tablet, film coated 600 mg Current Unavailable Manufacturing 5/01/2026 olmesartan medoxomil~hydrochlorothiazide Tablet 40 mg~12.5 mg Current Unavailable Manufacturing 5/01/2026 sildenafil citrate Tablet, film coated 70.24 mg Current Unavailable Commercial Changes / Commercial viability 5/01/2026 prilocaine hydrochloride Injection, solution 100 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 5/01/2026 cefalexin monohydrate Capsule, hard 250 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 5/01/2026 - 2026.01.04
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated bupivacaine hydrochloride Injection, solution 5 mg/mL Current Unavailable Manufacturing 2/01/2026 morphine sulfate pentahydrate Tablet, modified release 10 mg Current Unavailable Manufacturing 2/01/2026 morphine sulfate pentahydrate Tablet, modified release 30 mg Current Unavailable Manufacturing 2/01/2026 morphine sulfate pentahydrate Tablet, modified release 60 mg Current Unavailable Manufacturing 2/01/2026 morphine sulfate pentahydrate Tablet, modified release 100 mg Current Unavailable Manufacturing 2/01/2026 ciprofloxacin hydrochloride Tablet, film coated 555 mg Anticipated Available Manufacturing 2/01/2026 olanzapine pamoate monohydrate Injection, powder for 931 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 2/01/2026 olanzapine pamoate monohydrate Injection, powder for 690 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 2/01/2026 olanzapine pamoate monohydrate Injection, powder for 483 mg Resolved Available Transport / Logistic issues / Storage capacity issues 2/01/2026 bisoprolol fumarate Tablet 2.5 mg Current Limited Availability Manufacturing 2/01/2026 exemestane Tablet, sugar coated 25 mg Current Limited Availability Manufacturing 2/01/2026 phenobarbital Tablet, uncoated 30 mg Current Unavailable Manufacturing 2/01/2026 quetiapine fumarate Tablet, modified release 345.39 mg Resolved Available Manufacturing 2/01/2026 quetiapine fumarate Tablet, modified release 460.52 mg Resolved Available Manufacturing 2/01/2026 quetiapine fumarate Tablet, modified release 345.39 mg Resolved Available Manufacturing 2/01/2026 quetiapine fumarate Tablet, modified release 57.565 mg Anticipated Available Manufacturing 2/01/2026 clevidipine Injection, emulsion 25 mg Resolved Available Unexpected increase in consumer demand 2/01/2026 Pegvisomant Injection, powder for 10 mg Anticipated Available Manufacturing 2/01/2026 amlodipine besilate~olmesartan medoxomil Tablet, film coated 6.935 mg~40 mg Anticipated Available Manufacturing 2/01/2026 ondansetron Tablet, orally disintegrating 4 mg Current Limited Availability Manufacturing 2/01/2026 latanoprost~timolol maleate Eye Drops, solution .05 mg/mL~6.83 mg/mL Current Unavailable Manufacturing 2/01/2026 Semaglutide Injection, solution 1.34 mg/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 2/01/2026 dimethyl fumarate Capsule, enteric 240 mg Resolved Available Manufacturing 2/01/2026 lamotrigine Tablet, chewable 100 mg Resolved Available Manufacturing 2/01/2026 lamotrigine Tablet, chewable 200 mg Resolved Available Manufacturing 2/01/2026 prucalopride succinate Tablet 1.321 mg Current Unavailable Manufacturing 2/01/2026 prucalopride succinate Tablet 2.642 mg Current Unavailable Manufacturing 2/01/2026 amphotericin B Injection, powder for 50 mg Anticipated Available Manufacturing 2/01/2026 naltrexone hydrochloride Tablet, film coated 50 mg Current Unavailable Manufacturing 2/01/2026 tofacitinib citrate Solution 1.62 mg/mL Resolved Available Manufacturing 2/01/2026 aggregated albumin~Albumin~stannous chloride Injection, powder for 2.25 mg~.25 mg~.21 mg Current Unavailable Commercial Changes / Commercial viability 2/01/2026 ciprofloxacin hydrochloride Tablet, film coated 873.32 mg Current Unavailable Manufacturing 2/01/2026 carbidopa monohydrate~entacapone~levodopa Tablet, film coated 27 mg~200 mg~100 mg Anticipated Available Manufacturing 2/01/2026 digoxin Injection, solution .25 mg/mL Current Unavailable Manufacturing 24/12/2025 metoprolol tartrate Injection, solution 1 mg/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 24/12/2025 lidocaine Spray, solution 100 mg/mL Anticipated Available Manufacturing 24/12/2025 benzathine benzylpenicillin tetrahydrate Injection, suspension 1200000 USP Unit Current Limited Availability Manufacturing 24/12/2025 silver sulfadiazine Cream 10 mg/g Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 24/12/2025 silver sulfadiazine Cream 10 mg/g Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 24/12/2025 barium sulfate Suspension, powder for 98.453 % w/w Current Emergency Supply Only 24/12/2025 benzathine benzylpenicillin tetrahydrate Injection, suspension 600000 USP Unit Current Unavailable Manufacturing 24/12/2025 ramipril Tablet, uncoated 2.5 mg Resolved Available Manufacturing 24/12/2025 lidocaine hydrochloride Injection, solution 10 mg/mL Anticipated Available Manufacturing 24/12/2025 lamotrigine Tablet 200 mg Current Unavailable Manufacturing 24/12/2025 methylphenidate hydrochloride Capsule, modified release 40 mg Current Unavailable Manufacturing 24/12/2025 terbutaline sulfate Injection, solution .5 mg/mL Resolved Available Manufacturing 23/12/2025 erythromycin lactobionate Injection, powder for 1515 mg Anticipated Available Manufacturing 23/12/2025 tranexamic acid Tablet, film coated 500 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 23/12/2025 sulfamethoxazole~trimethoprim Injection, concentrated 80 mg/mL~16 mg/mL Current Unavailable Manufacturing 23/12/2025 Choriogonadotropin alfa Injection, solution 250 microgram Current Limited Availability Unexpected increase in consumer demand 23/12/2025 montelukast sodium Tablet, chewable 5.2 mg Anticipated Available Manufacturing 23/12/2025 montelukast sodium Tablet, chewable 5.2 mg Anticipated Available Manufacturing 23/12/2025 pramipexole dihydrochloride monohydrate Tablet 1 mg Anticipated Available Manufacturing 23/12/2025 levetiracetam Solution 100 mg/mL Current Limited Availability Manufacturing 23/12/2025 tranexamic acid Tablet, film coated 500 mg Current Unavailable Manufacturing 23/12/2025 tranexamic acid Tablet, film coated 500 mg Current Unavailable Manufacturing 23/12/2025 tranexamic acid Tablet, film coated 500 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 23/12/2025 nimodipine Tablet, film coated 30 mg Anticipated Available Manufacturing 23/12/2025 prazosin hydrochloride Tablet, uncoated 1.095 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 22/12/2025 prazosin hydrochloride Tablet, uncoated 5.476 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 22/12/2025 posaconazole Suspension 40 mg/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 22/12/2025 glimepiride Tablet, uncoated 2 mg Current Unavailable Manufacturing 22/12/2025 minoxidil Tablet, uncoated 10 mg Resolved Available Manufacturing 22/12/2025 midazolam Injection, solution 1 mg/mL Current Limited Availability Manufacturing 22/12/2025 dantrolene sodium hemiheptahydrate Injection, powder for 20 mg Anticipated Available Manufacturing 22/12/2025 galantamine hydrobromide Capsule, modified release 20.512 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 22/12/2025 calcium folinate hydrate Tablet, uncoated 18.6 mg Anticipated Available Unexpected increase in consumer demand 22/12/2025 remifentanil hydrochloride Injection, powder for 1.097 mg Current Limited Availability Manufacturing 22/12/2025 ropivacaine hydrochloride Injection, solution 2 mg/mL Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 22/12/2025 ropivacaine hydrochloride Injection, solution 7.5 mg/mL Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 22/12/2025 finasteride Tablet, film coated 5 mg Current Limited Availability Manufacturing 22/12/2025 voriconazole Tablet, film coated 50 mg Current Unavailable Manufacturing 22/12/2025 lansoprazole Tablet, orally disintegrating 15 mg Current Unavailable Manufacturing 22/12/2025 lansoprazole Tablet, orally disintegrating 30 mg Current Unavailable Manufacturing 22/12/2025 betahistine dihydrochloride Tablet 16 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 22/12/2025 risperidone Tablet, film coated .5 mg Current Unavailable Commercial Changes / Commercial viability 22/12/2025 olmesartan medoxomil~hydrochlorothiazide Tablet 40 mg~12.5 mg Current Limited Availability Manufacturing 22/12/2025 solifenacin succinate Tablet, film coated 5 mg Current Unavailable Manufacturing 22/12/2025 teriflunomide Tablet, film coated 14 mg Current Limited Availability Manufacturing 22/12/2025 metaraminol tartrate Injection, solution 19 mg Resolved Available Manufacturing 22/12/2025 sunitinib Capsule 12.5 mg Current Unavailable Manufacturing 22/12/2025 isotretinoin Capsule, soft 20 mg Current Limited Availability Manufacturing 22/12/2025 sitagliptin hydrochloride monohydrate~metformin hydrochloride Tablet, modified release 56.685 mg~1000 mg Current Unavailable Manufacturing 22/12/2025 mivacurium chloride Injection, solution 2.14 mg/mL Discontinued Unavailable Manufacturing 22/12/2025 mefloquine hydrochloride Tablet, uncoated 274.09 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 22/12/2025 carboplatin Injection, solution 450 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 22/12/2025 pramipexole dihydrochloride monohydrate Tablet, uncoated .25 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 22/12/2025 parecoxib sodium Injection, powder for 42.36 mg Anticipated Available Manufacturing 22/12/2025 alprostadil Injection, powder for 20 microgram/mL Current Unavailable Unexpected increase in consumer demand 22/12/2025 alprostadil Injection, powder for 40 microgram/mL Current Unavailable Manufacturing 22/12/2025 - 2025.12.22
rifampicin Oral Liquid 20 mg/mL Anticipated Available Unexpected increase in consumer demand 19/12/2025 salbutamol sulfate Inhalation, conventional 3 mg Current Unavailable Manufacturing 19/12/2025 salbutamol sulfate Inhalation, conventional 6 mg Current Unavailable Manufacturing 19/12/2025 topiramate Tablet, film coated 50 mg Resolved Available Manufacturing 19/12/2025 ciprofloxacin hydrochloride Tablet, film coated 832.5 mg Current Limited Availability Manufacturing 19/12/2025 lamotrigine Tablet, chewable 200 mg Resolved Available Manufacturing 19/12/2025 olanzapine Tablet, orally disintegrating 5 mg Resolved Available Manufacturing 19/12/2025 pramipexole dihydrochloride monohydrate Tablet .125 mg Current Unavailable Manufacturing 19/12/2025 pramipexole dihydrochloride monohydrate Tablet 1 mg Current Limited Availability Manufacturing 19/12/2025 exemestane Tablet, sugar coated 25 mg Current Limited Availability Manufacturing 19/12/2025 quetiapine fumarate Tablet, modified release 345.39 mg Current Unavailable Manufacturing 19/12/2025 quetiapine fumarate Tablet, modified release 230.26 mg Current Limited Availability Manufacturing 19/12/2025 clindamycin hydrochloride Capsule, hard 162.87 mg Resolved Available Manufacturing 19/12/2025 levetiracetam Injection, intravenous infusion 100 mg/mL Anticipated Available Manufacturing 19/12/2025 phenylephrine hydrochloride~prednisolone acetate Eye Drops, suspension 1.2 mg/mL~10 mg/mL Current Limited Availability Unexpected increase in consumer demand 19/12/2025 isotretinoin Capsule, soft 20 mg Anticipated Available Manufacturing 19/12/2025 irbesartan Tablet, film coated 75 mg Current Unavailable Manufacturing 19/12/2025 olmesartan medoxomil~hydrochlorothiazide Tablet 20 mg~12.5 mg Current Unavailable Manufacturing 19/12/2025 acamprosate calcium Tablet, enteric coated 333 mg Resolved Available Manufacturing 19/12/2025 lacosamide Tablet, film coated 50 mg Anticipated Available Manufacturing 19/12/2025 risperidone Tablet, film coated 2 mg Current Limited Availability Manufacturing 19/12/2025 lorazepam Tablet 1 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 19/12/2025 lamotrigine Tablet, chewable 200 mg Current Limited Availability Manufacturing 19/12/2025 levothyroxine sodium Tablet, uncoated 200 microgram Current Unavailable Manufacturing 19/12/2025 risperidone Oral Liquid, solution 1 mg/mL Current Unavailable Manufacturing 19/12/2025 ondansetron hydrochloride dihydrate Tablet, film coated 4.986 mg Current Limited Availability Manufacturing 19/12/2025 anastrozole Tablet, film coated 1 mg Anticipated Available Manufacturing 19/12/2025 hydralazine hydrochloride Injection, powder for 20 mg Current Unavailable Manufacturing 19/12/2025 isotretinoin Capsule, soft 20 mg Current Unavailable Manufacturing 19/12/2025 isotretinoin Capsule, soft 10 mg Current Unavailable Manufacturing 19/12/2025 teicoplanin~water for injections Diluent, not applicable~Injection, powder for 400 mg~3.14 mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 19/12/2025 alfuzosin hydrochloride Tablet, modified release 10 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 19/12/2025 sodium pyrophosphate Injection, powder for 30 mg Current Unavailable Manufacturing 18/12/2025 doxorubicin hydrochloride Injection 2 mg/mL Anticipated Available Manufacturing 18/12/2025 atomoxetine hydrochloride Capsule, hard 11.43 mg Current Unavailable Manufacturing 18/12/2025 cyproterone acetate Tablet, uncoated 100 mg Anticipated Available Manufacturing 18/12/2025 ambrisentan Tablet, film coated 5 mg Anticipated Available Manufacturing 18/12/2025 dantrolene sodium hemiheptahydrate Injection, powder for 20 mg Anticipated Available Manufacturing 17/12/2025 glipizide Tablet, uncoated 5 mg Resolved Available Manufacturing 17/12/2025 cyproterone acetate Tablet, uncoated 50 mg Current Limited Availability Manufacturing 17/12/2025 plerixafor Injection, solution 20 mg/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 17/12/2025 pramipexole dihydrochloride monohydrate Tablet .125 mg Current Unavailable Manufacturing 17/12/2025 atorvastatin calcium trihydrate Tablet, film coated 43.38 mg Current Unavailable Manufacturing 17/12/2025 metformin hydrochloride Tablet, film coated 1000 mg Current Unavailable Manufacturing 17/12/2025 armodafinil Tablet, uncoated 250 mg Resolved Available Transport / Logistic issues / Storage capacity issues 17/12/2025 armodafinil Tablet, uncoated 150 mg Resolved Available Transport / Logistic issues / Storage capacity issues 17/12/2025 cisatracurium besilate Injection, solution 7.04 mg Current Limited Availability Manufacturing 17/12/2025 metformin hydrochloride Tablet, modified release 500 mg Current Unavailable Manufacturing 17/12/2025 risperidone Oral Liquid, solution 1 mg/mL Current Unavailable Manufacturing 17/12/2025 levothyroxine sodium Tablet .075 mg Anticipated Available Manufacturing 17/12/2025 ramipril Tablet, uncoated 1.25 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 17/12/2025 Teriparatide Injection, solution 250 microgram/mL Current Unavailable Manufacturing 17/12/2025 metronidazole Tablet, film coated 400 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 17/12/2025 stannous chloride dihydrate Injection, powder for 19.2 microgram/mL Current Emergency Supply Only Manufacturing 17/12/2025 carbidopa monohydrate~levodopa Tablet, uncoated 26.9 mg~100 mg Anticipated Available Manufacturing 17/12/2025 labetalol hydrochloride Tablet, film coated 200 mg Anticipated Available Manufacturing 17/12/2025 olanzapine Tablet, film coated 5 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 17/12/2025 midazolam Injection, solution 1 mg/mL Resolved Available Manufacturing 17/12/2025 hydrochlorothiazide~enalapril maleate Tablet, uncoated 6 mg~20 mg Resolved Available Manufacturing 17/12/2025 olanzapine Wafer 5 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 17/12/2025 cefalexin monohydrate Capsule, hard 263 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 17/12/2025 metformin hydrochloride Tablet, film coated 500 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 17/12/2025 etoposide phosphate Injection, powder for 1136 mg Anticipated Available Manufacturing 17/12/2025 gabapentin Capsule, hard 400 mg Current Limited Availability Manufacturing 16/12/2025 cyproterone acetate Tablet, uncoated 50 mg Current Unavailable Unexpected increase in consumer demand 16/12/2025 calcitonin salmon Injection, solution 100 IU/mL Anticipated Available Unexpected increase in consumer demand 16/12/2025 valaciclovir Tablet, film coated 500 mg Resolved Available Manufacturing 16/12/2025 benzathine benzylpenicillin tetrahydrate Injection, suspension 1200000 USP Unit Current Limited Availability Manufacturing 16/12/2025 galantamine hydrobromide Capsule, modified release 20.512 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 16/12/2025 galantamine hydrobromide Capsule, modified release 30.768 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 16/12/2025 leflunomide Tablet, film coated 20 mg Resolved Available Manufacturing 16/12/2025 Somatropin Injection, powder for 12 mg/mL Resolved Available Unexpected increase in consumer demand 16/12/2025 atorvastatin calcium trihydrate Tablet, film coated 86.76 mg Current Limited Availability Manufacturing 16/12/2025 atorvastatin calcium trihydrate Tablet, film coated 21.69 mg Current Unavailable Manufacturing 16/12/2025 valsartan~hydrochlorothiazide Tablet, film coated 160 mg~12.5 mg Anticipated Available Manufacturing 16/12/2025 oseltamivir phosphate Oral Liquid, powder for 7.88 mg/mL Current Limited Availability Unexpected increase in consumer demand 16/12/2025 levodopa~carbidopa monohydrate~entacapone Tablet, film coated 200 mg~54 mg~200 mg Resolved Available Manufacturing 16/12/2025 levodopa~carbidopa monohydrate~entacapone Tablet, film coated 75 mg~20.25 mg~200 mg Resolved Available Manufacturing 16/12/2025 carbidopa monohydrate~entacapone~levodopa Tablet, film coated 13.5 mg~200 mg~50 mg Resolved Available Manufacturing 16/12/2025 levodopa~entacapone~carbidopa monohydrate Tablet, film coated 100 mg~200 mg~27 mg Resolved Available Manufacturing 16/12/2025 entacapone~levodopa~carbidopa monohydrate Tablet, film coated 200 mg~125 mg~33.75 mg Resolved Available Manufacturing 16/12/2025 entacapone~carbidopa monohydrate~levodopa Tablet, film coated 200 mg~40.5 mg~150 mg Resolved Available Manufacturing 16/12/2025 risperidone Tablet, film coated 3 mg Current Limited Availability Manufacturing 16/12/2025 methylphenidate hydrochloride Capsule, modified release 60 mg Current Limited Availability Manufacturing 16/12/2025 quetiapine fumarate Tablet, modified release 57.5 mg Current Limited Availability Unexpected increase in consumer demand 16/12/2025 stiripentol Capsule 500 mg Anticipated Available Manufacturing 16/12/2025 lacosamide Tablet, film coated 100 mg Resolved Available Manufacturing 16/12/2025 metaraminol tartrate Injection, solution 19 mg Current Unavailable Manufacturing 16/12/2025 montelukast sodium Tablet, chewable 5.2 mg Resolved Available Manufacturing 16/12/2025 nitrofurantoin Capsule, hard 100 mg Current Unavailable Unexpected increase in consumer demand 16/12/2025 sacubitril~valsartan Tablet, film coated 97.2 mg~102.8 mg Current Unavailable Manufacturing 16/12/2025 rivaroxaban Tablet, film coated 15 mg Resolved Available Manufacturing 16/12/2025 nitrofurantoin Capsule, hard 100 mg Current Limited Availability Unexpected increase in consumer demand 16/12/2025 aripiprazole monohydrate Injection, powder for 416.07 mg Current Unavailable Manufacturing 16/12/2025 lidocaine hydrochloride Injection, solution 10 mg/mL Resolved Available Manufacturing 16/12/2025 pramipexole dihydrochloride monohydrate Tablet, uncoated 1 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 16/12/2025 pramipexole dihydrochloride monohydrate Tablet, uncoated .125 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 16/12/2025 diltiazem hydrochloride Capsule, modified release 180 mg Current Limited Availability Manufacturing 16/12/2025 diltiazem hydrochloride Capsule, modified release 360 mg Current Unavailable Manufacturing 16/12/2025 diltiazem hydrochloride Capsule, modified release 360 mg Anticipated Available Manufacturing 16/12/2025 flunitrazepam Tablet, film coated 1 mg Current Limited Availability Manufacturing 16/12/2025 methylphenidate hydrochloride Capsule, modified release 20 mg Current Limited Availability Manufacturing 16/12/2025 methylphenidate hydrochloride Capsule, modified release 30 mg Resolved Available Manufacturing 16/12/2025 methylphenidate hydrochloride Capsule, modified release 40 mg Current Unavailable Manufacturing 16/12/2025 simvastatin Tablet, film coated 5 mg Current Limited Availability Manufacturing 16/12/2025 Pancreatic extract Capsule, enteric 300 mg Current Limited Availability Unexpected increase in consumer demand 15/12/2025 lansoprazole Capsule, enteric 30 mg Resolved Available Manufacturing 15/12/2025 avanafil Tablet, uncoated 200 mg Anticipated Available Unexpected increase in consumer demand 15/12/2025 benzathine benzylpenicillin tetrahydrate Injection, suspension 600000 USP Unit Current Unavailable Manufacturing 15/12/2025 lacosamide Tablet, film coated 50 mg Resolved Available Manufacturing 15/12/2025 lacosamide Tablet, film coated 150 mg Resolved Available Manufacturing 15/12/2025 Pancreatic extract Capsule 420 mg Current Limited Availability Unexpected increase in consumer demand 15/12/2025 estradiol Drug delivery system, transdermal 1.17 mg Current Unavailable Manufacturing 15/12/2025 lanreotide acetate Injection, solution 133.33 mg Current Unavailable Manufacturing 15/12/2025 lanreotide acetate Injection, solution 100 mg Current Unavailable Manufacturing 15/12/2025 imipramine hydrochloride Tablet, sugar coated 25 mg Current Unavailable Manufacturing 15/12/2025 - 2025.12.15
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated gabapentin Capsule, hard 400 mg Current Limited Availability Manufacturing 12/12/2025 prazosin hydrochloride Tablet, uncoated 5.476 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 12/12/2025 clindamycin phosphate Injection, solution 0 QS Anticipated Available Manufacturing 12/12/2025 aripiprazole Tablet, uncoated 10 mg Anticipated Available Manufacturing 12/12/2025 tacrolimus monohydrate Capsule, hard 5.112 mg Anticipated Available Manufacturing 12/12/2025 pramipexole dihydrochloride monohydrate Tablet .25 mg Current Limited Availability Manufacturing 12/12/2025 montelukast sodium Tablet, chewable 5.2 mg Anticipated Available Manufacturing 12/12/2025 cisatracurium besilate Injection, solution 14.07 mg Current Limited Availability Manufacturing 12/12/2025 citalopram hydrobromide Tablet, film coated 49.98 mg Anticipated Available Manufacturing 12/12/2025 carbidopa monohydrate~levodopa~entacapone Tablet, film coated 54.1 mg~200 mg~200 mg Current Unavailable Unexpected increase in consumer demand 12/12/2025 Pegvisomant Injection, powder for 10 mg Anticipated Available Manufacturing 12/12/2025 amlodipine besilate~olmesartan medoxomil Tablet, film coated 6.935 mg~40 mg Anticipated Available Manufacturing 12/12/2025 lacosamide Tablet, film coated 150 mg Anticipated Available Manufacturing 12/12/2025 lorazepam Tablet 1 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 12/12/2025 timolol maleate~latanoprost Eye Drops, solution 6.83 mg/mL~.05 mg/mL Current Limited Availability Manufacturing 12/12/2025 paroxetine hydrochloride Tablet, film coated 22.22 mg Current Limited Availability Manufacturing 12/12/2025 ciprofloxacin hydrochloride Tablet, film coated 582.21 mg Anticipated Available Manufacturing 12/12/2025 lamotrigine Tablet, chewable 100 mg Current Unavailable Manufacturing 12/12/2025 lamotrigine Tablet, chewable 200 mg Anticipated Available Manufacturing 12/12/2025 nitrofurantoin Capsule, hard 100 mg Current Limited Availability Unexpected increase in consumer demand 12/12/2025 tofacitinib citrate Solution 1.62 mg/mL Anticipated Available Manufacturing 12/12/2025 ondansetron hydrochloride dihydrate Tablet, film coated 4.986 mg Anticipated Available Manufacturing 12/12/2025 doxepin hydrochloride Capsule, hard 28.25 mg Current Limited Availability Manufacturing 12/12/2025 clonidine hydrochloride Tablet, uncoated 150 microgram Current Limited Availability Manufacturing 12/12/2025 salbutamol sulfate Inhalation, conventional 3 mg Current Unavailable Manufacturing 11/12/2025 salbutamol sulfate Inhalation, conventional 6 mg Current Unavailable Manufacturing 11/12/2025 salbutamol sulfate Inhalation 2.4 mg/mL Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 11/12/2025 nortriptyline Tablet, film coated 10 mg Resolved Available Manufacturing 11/12/2025 bisoprolol fumarate Tablet 2.5 mg Current Unavailable Manufacturing 11/12/2025 ondansetron hydrochloride dihydrate Tablet, film coated 9.972 mg Current Limited Availability Manufacturing 11/12/2025 atorvastatin calcium trihydrate Tablet, film coated 43.38 mg Resolved Available Manufacturing 11/12/2025 indapamide hemihydrate Tablet, sugar coated 2.5 mg Current Unavailable Manufacturing 11/12/2025 montelukast sodium Tablet, chewable 4.16 mg Current Unavailable Manufacturing 11/12/2025 enalapril maleate Tablet 5 mg Current Unavailable Manufacturing 11/12/2025 levodopa~carbidopa monohydrate~entacapone Tablet, film coated 100 mg~27 mg~200 mg Current Unavailable Unexpected increase in consumer demand 11/12/2025 ezetimibe Tablet, uncoated 10 mg Current Limited Availability Unexpected increase in consumer demand 11/12/2025 irbesartan Tablet, film coated 150 mg Anticipated Available Manufacturing 11/12/2025 tobramycin Inhalation, conventional 60 mg/mL Anticipated Available Manufacturing 11/12/2025 bimatoprost Eye Drops .3 mg/mL Anticipated Available Manufacturing 11/12/2025 erenumab Injection, solution 70 mg Current Limited Availability Unexpected increase in consumer demand 11/12/2025 crisaborole Ointment 2 % w/w Anticipated Available Unexpected increase in consumer demand 11/12/2025 gabapentin Tablet, film coated 600 mg Resolved Available Manufacturing 11/12/2025 sitagliptin hydrochloride monohydrate~metformin hydrochloride Tablet, modified release 56.685 mg~1000 mg Current Unavailable Manufacturing 11/12/2025 nitrofurantoin Capsule, hard 50 mg Anticipated Available Manufacturing 11/12/2025 Teriparatide Injection, solution .25 mg/mL Anticipated Available Manufacturing 11/12/2025 levothyroxine sodium Tablet, uncoated .05 mg Resolved Available Manufacturing 11/12/2025 rifampicin Oral Liquid 20 mg/mL Anticipated Available Unexpected increase in consumer demand 10/12/2025 metformin hydrochloride Tablet, film coated 850 mg Current Unavailable Manufacturing 10/12/2025 lansoprazole Capsule, enteric 30 mg Current Limited Availability Manufacturing 10/12/2025 lamivudine Tablet, film coated 300 mg Current Limited Availability Manufacturing 10/12/2025 lansoprazole Tablet, orally disintegrating 30 mg Current Limited Availability Manufacturing 10/12/2025 isotretinoin Capsule, soft 20 mg Current Unavailable Manufacturing 10/12/2025 azithromycin Injection, powder for 500 mg Current Unavailable Commercial Changes / Commercial viability 10/12/2025 ropivacaine hydrochloride Injection, solution 75 mg Resolved Available Transport / Logistic issues / Storage capacity issues 10/12/2025 ropivacaine hydrochloride Injection, solution 200 mg Resolved Available Transport / Logistic issues / Storage capacity issues 10/12/2025 lurasidone hydrochloride Tablet, film coated 80 mg Discontinued Unavailable Commercial Changes / Commercial viability 10/12/2025 metformin hydrochloride Tablet, film coated 1000 mg Current Unavailable Manufacturing 10/12/2025 isotretinoin Capsule, soft 10 mg Current Limited Availability Manufacturing 10/12/2025 fluorouracil Injection, solution 50 mg/mL Resolved Available Manufacturing 10/12/2025 doxepin hydrochloride Capsule, hard 11.3 mg Current Limited Availability Manufacturing 10/12/2025 aprepitant Capsule, hard 165 mg Anticipated Available Manufacturing 10/12/2025 montelukast sodium Tablet, chewable 5.2 mg Current Unavailable Manufacturing 10/12/2025 isotretinoin Capsule, soft 10 mg Current Unavailable Manufacturing 10/12/2025 perindopril erbumine Tablet, uncoated 2 mg Discontinued Unavailable Commercial Changes / Commercial viability 10/12/2025 perindopril erbumine Tablet, uncoated 4 mg Discontinued Unavailable Commercial Changes / Commercial viability 10/12/2025 levothyroxine sodium Tablet, uncoated 75 microgram Current Unavailable Manufacturing 10/12/2025 levothyroxine sodium Tablet, uncoated 200 microgram Current Unavailable Manufacturing 10/12/2025 tetrabenazine Tablet, uncoated 25 mg Current Unavailable Manufacturing 10/12/2025 isotretinoin Capsule, soft 20 mg Current Unavailable Manufacturing 10/12/2025 isotretinoin Capsule, soft 10 mg Current Limited Availability Manufacturing 10/12/2025 stannous chloride dihydrate Injection, powder for 19.2 microgram/mL Anticipated Available Manufacturing 10/12/2025 perindopril erbumine Tablet, uncoated 8 mg Discontinued Unavailable Commercial Changes / Commercial viability 10/12/2025 ceftazidime pentahydrate Injection, powder for 2.328 g Resolved Available Manufacturing 9/12/2025 hydromorphone hydrochloride Injection, solution 10 mg/mL Discontinued Unavailable Commercial Changes / Commercial viability 9/12/2025 prasugrel Tablet, film coated 5 mg Resolved Available Commercial Changes / Commercial viability 9/12/2025 dantrolene sodium hemiheptahydrate Capsule 25 mg Current Unavailable Manufacturing 9/12/2025 dantrolene sodium hemiheptahydrate Capsule 50 mg Current Unavailable Manufacturing 9/12/2025 eptifibatide Injection, solution 20 mg Current Unavailable Manufacturing 9/12/2025 mefloquine hydrochloride Tablet, uncoated 274.09 mg Anticipated Available Transport / Logistic issues / Storage capacity issues 9/12/2025 alprostadil Injection, solution 500 microgram/mL Anticipated Available Manufacturing 9/12/2025 labetalol hydrochloride Tablet, film coated 100 mg Resolved Available Manufacturing 9/12/2025 desferrioxamine mesilate Injection, powder for 2 g Anticipated Available Manufacturing 9/12/2025 betiatide Injection, powder for 1 mg Current Unavailable Manufacturing 8/12/2025 drospirenone~ethinylestradiol Tablet 3 mg~30 microgram Resolved Available Manufacturing 8/12/2025 milrinone Injection, concentrated 10 mg Current Unavailable Manufacturing 8/12/2025 temozolomide Capsule, hard 20 mg Anticipated Available Manufacturing 8/12/2025 paclitaxel Injection, concentrated 300 mg Resolved Available Manufacturing 8/12/2025 citalopram hydrobromide Tablet, film coated 12.495 mg Current Limited Availability Manufacturing 8/12/2025 pregabalin Capsule, hard 25 mg Resolved Available Manufacturing 8/12/2025 lamotrigine Tablet, uncoated 100 mg Current Unavailable Manufacturing 8/12/2025 hydrocortisone Tablet, uncoated 4 mg Resolved Available Manufacturing 8/12/2025 levothyroxine sodium Tablet, uncoated 100 microgram Current Unavailable Manufacturing 8/12/2025 levothyroxine sodium Tablet, uncoated 50 microgram Current Unavailable Manufacturing 8/12/2025 thiotepa Injection, powder for 15 mg Current Unavailable Commercial Changes / Commercial viability 8/12/2025 thiotepa Injection, powder for 100 mg Current Unavailable Commercial Changes / Commercial viability 8/12/2025 thiotepa Injection, powder for 400 mg Current Unavailable Commercial Changes / Commercial viability 8/12/2025 clopidogrel hydrogen sulfate Tablet, film coated 97.875 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 8/12/2025 tranexamic acid Tablet, film coated 500 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 8/12/2025 bleomycin sulfate Injection, powder for 15000 IU Resolved Available Manufacturing 8/12/2025 dexamethasone~framycetin sulfate~gramicidin Ear Drops .5 mg/mL~5 mg/mL~.05 mg/mL Current Limited Availability Manufacturing 8/12/2025 pramipexole dihydrochloride monohydrate Tablet, uncoated .125 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 8/12/2025 midazolam Injection, solution 1 mg/mL Current Unavailable Manufacturing 8/12/2025 simvastatin Tablet, film coated 5 mg Current Limited Availability Manufacturing 8/12/2025 - 2025.12.08
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated levothyroxine sodium Tablet, uncoated 100 microgram Current Unavailable Manufacturing 8/12/2025 levothyroxine sodium Tablet, uncoated 50 microgram Current Unavailable Manufacturing 8/12/2025 thiotepa Injection, powder for 15 mg Current Unavailable Commercial Changes / Commercial viability 8/12/2025 thiotepa Injection, powder for 100 mg Current Unavailable Commercial Changes / Commercial viability 8/12/2025 thiotepa Injection, powder for 400 mg Current Unavailable Commercial Changes / Commercial viability 8/12/2025 simvastatin Tablet, film coated 5 mg Current Limited Availability Manufacturing 8/12/2025 trandolapril Capsule 2 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 5/12/2025 topiramate Tablet, film coated 25 mg Current Unavailable Manufacturing 5/12/2025 pioglitazone hydrochloride Tablet 49.9 mg Resolved Available Manufacturing 5/12/2025 hydrochlorothiazide~valsartan Tablet, film coated 12.5 mg~160 mg Anticipated Available Manufacturing 5/12/2025 phenobarbital Tablet, uncoated 30 mg Current Unavailable Manufacturing 5/12/2025 quetiapine fumarate Tablet, film coated 115.12 mg Resolved Available Commercial Changes / Commercial viability 5/12/2025 quetiapine fumarate Tablet, film coated 345.36 mg Resolved Available Commercial Changes / Commercial viability 5/12/2025 pramipexole dihydrochloride monohydrate Tablet .125 mg Current Unavailable Unexpected increase in consumer demand 5/12/2025 citalopram hydrobromide Tablet, film coated 12.495 mg Current Limited Availability Manufacturing 5/12/2025 ezetimibe Tablet, uncoated 10 mg Discontinued Reduction in supply until supply is exhausted Unexpected increase in consumer demand 5/12/2025 ezetimibe Tablet, uncoated 10 mg Current Unavailable Unexpected increase in consumer demand 5/12/2025 ezetimibe Tablet, uncoated 10 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 5/12/2025 moxonidine Tablet, film coated 200 microgram Current Limited Availability Commercial Changes / Commercial viability 5/12/2025 mebeverine hydrochloride Tablet, film coated 135 mg Resolved Available Manufacturing 5/12/2025 eplerenone Tablet, film coated 50 mg Current Limited Availability Manufacturing 5/12/2025 eplerenone Tablet, film coated 25 mg Current Limited Availability Manufacturing 5/12/2025 lacosamide Tablet, film coated 50 mg Resolved Available Manufacturing 5/12/2025 lacosamide Tablet, film coated 150 mg Current Unavailable Manufacturing 5/12/2025 amlodipine besilate~olmesartan medoxomil~hydrochlorothiazide Tablet, film coated 13.9 mg~40 mg~12.5 mg Resolved Available Manufacturing 5/12/2025 montelukast sodium Tablet, film coated 10.4 mg Current Limited Availability Manufacturing 5/12/2025 atracurium besilate Injection, solution 10 mg/mL Current Limited Availability Manufacturing 5/12/2025 pramipexole dihydrochloride monohydrate Tablet, uncoated 1 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 5/12/2025 flunitrazepam Tablet, film coated 1 mg Current Limited Availability Manufacturing 5/12/2025 tobramycin Injection, solution 80 mg Current Emergency Supply Only Manufacturing 4/12/2025 phenytoin sodium Injection, solution 250 mg Current Unavailable Manufacturing 4/12/2025 phenytoin sodium Injection, solution 100 mg Current Unavailable Manufacturing 4/12/2025 methylprednisolone sodium succinate Injection, powder for 663.13 mg Anticipated Available Manufacturing 4/12/2025 dantrolene sodium hemiheptahydrate Injection, powder for 20 mg Anticipated Available Manufacturing 4/12/2025 nortriptyline Tablet, film coated 10 mg Anticipated Available Manufacturing 4/12/2025 midazolam Injection, solution 15 mg Current Limited Availability Manufacturing 4/12/2025 midazolam Injection, solution 50 mg Resolved Available Manufacturing 4/12/2025 trimethoprim~sulfamethoxazole Injection, concentrated 16 mg/mL~80 mg/mL Current Unavailable Manufacturing 4/12/2025 bisoprolol fumarate Tablet 5 mg Resolved Available Manufacturing 4/12/2025 rocuronium bromide Injection, solution 50 mg Anticipated Available Manufacturing 4/12/2025 sildenafil citrate Tablet, film coated 140.45 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 4/12/2025 omeprazole Capsule, enteric 20 mg Current Limited Availability Manufacturing 4/12/2025 indapamide hemihydrate~perindopril erbumine Tablet 1.25 mg~4 mg Current Unavailable Manufacturing 4/12/2025 simvastatin~ezetimibe Tablet 10 mg~10 mg Current Unavailable Manufacturing 4/12/2025 simvastatin~ezetimibe Tablet 80 mg~10 mg Anticipated Available Manufacturing 4/12/2025 ezetimibe~simvastatin Tablet 10 mg~20 mg Current Unavailable Manufacturing 4/12/2025 ezetimibe~simvastatin Tablet 10 mg~40 mg Anticipated Available Manufacturing 4/12/2025 acarbose Tablet 50 mg Discontinued Unavailable Commercial Changes / Commercial viability 4/12/2025 acarbose Tablet 100 mg Discontinued Unavailable Commercial Changes / Commercial viability 4/12/2025 paclitaxel Injection, powder for 100 mg Resolved Available Manufacturing 4/12/2025 paroxetine hydrochloride Tablet, film coated 22.22 mg Current Limited Availability Manufacturing 4/12/2025 atorvastatin calcium trihydrate Tablet, film coated 86.751 mg Current Limited Availability Manufacturing 4/12/2025 lamotrigine Tablet, chewable 100 mg Current Unavailable Manufacturing 4/12/2025 daptomycin Injection, powder for 500 mg Current Unavailable Manufacturing 4/12/2025 daptomycin Inhalation, powder for 350 mg Current Unavailable Manufacturing 4/12/2025 isotretinoin Capsule, soft 10 mg Current Limited Availability Manufacturing 4/12/2025 alprostadil Injection, solution 500 microgram/mL Anticipated Available Manufacturing 4/12/2025 rifampicin Capsule, hard 150 mg Resolved Available Manufacturing 4/12/2025 rifampicin Capsule, hard 300 mg Resolved Available Manufacturing 4/12/2025 Insulin lispro Injection, solution 100 IU/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 4/12/2025 Alteplase Diluent, not applicable 10 mg Resolved Available Unexpected increase in consumer demand 4/12/2025 heparin sodium Injection, solution 10 IU/mL Current Unavailable Manufacturing 4/12/2025 nizatidine Capsule 300 mg Current Limited Availability Manufacturing 4/12/2025 sertraline hydrochloride Tablet, film coated 56 mg Anticipated Available Manufacturing 4/12/2025 sertraline hydrochloride Tablet, film coated 112 mg Anticipated Available Manufacturing 4/12/2025 dinoprostone Gel .3333 mg/g Current Emergency Supply Only Manufacturing 4/12/2025 dinoprostone Gel .6667 mg/g Current Emergency Supply Only Manufacturing 4/12/2025 venlafaxine Capsule, modified release 150 mg Current Unavailable Manufacturing 3/12/2025 insulin Injection, suspension 100 IU/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 3/12/2025 insulin Injection, solution 100 IU/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 3/12/2025 glipizide Tablet, uncoated 5 mg Anticipated Available Manufacturing 3/12/2025 ropivacaine hydrochloride Injection, solution 2 mg/mL Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 3/12/2025 ropivacaine hydrochloride Injection, solution 7.5 mg/mL Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 3/12/2025 lansoprazole Tablet, orally disintegrating 15 mg Resolved Available Unexpected increase in consumer demand 3/12/2025 tranexamic acid Tablet, film coated 500 mg Current Unavailable Manufacturing 3/12/2025 tranexamic acid Tablet, film coated 500 mg Current Unavailable Manufacturing 3/12/2025 lamotrigine Tablet, uncoated 100 mg Current Unavailable Manufacturing 3/12/2025 icatibant acetate Injection, solution 31.38 mg Resolved Available Manufacturing 3/12/2025 insulin Injection, suspension 100 IU/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 3/12/2025 tranexamic acid Tablet, film coated 500 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 3/12/2025 ropivacaine hydrochloride Injection, solution 2 mg/mL Current Unavailable Manufacturing 3/12/2025 mianserin hydrochloride Tablet, film coated 20 mg Resolved Available Manufacturing 3/12/2025 labetalol hydrochloride Tablet, film coated 100 mg Current Unavailable Manufacturing 3/12/2025 spironolactone Tablet, film coated 25 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 3/12/2025 tranexamic acid Tablet, film coated 500 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 2/12/2025 sodium nitroprusside Injection, solution 50 mg Resolved Available Manufacturing 2/12/2025 lansoprazole Tablet, orally disintegrating 30 mg Current Limited Availability Manufacturing 2/12/2025 nicorandil Tablet 20 mg Resolved Available Manufacturing 2/12/2025 nicorandil Tablet 10 mg Resolved Available Manufacturing 2/12/2025 hydrocortisone Tablet, uncoated 4 mg Current Unavailable Manufacturing 2/12/2025 daptomycin Injection, powder for 500 mg Resolved Available Manufacturing 2/12/2025 methyldopa sesquihydrate Tablet, film coated 283 mg Resolved Available Manufacturing 2/12/2025 dapsone Tablet, uncoated 25 mg Anticipated Available Manufacturing 1/12/2025 dapsone Tablet, uncoated 100 mg Anticipated Available Manufacturing 1/12/2025 indometacin Suppository, moulded 100 mg Resolved Available Manufacturing 1/12/2025 metoprolol tartrate Injection, solution 1 mg/mL Anticipated Available Manufacturing 1/12/2025 drospirenone~ethinylestradiol Tablet 3 mg~30 microgram Current Limited Availability Manufacturing 1/12/2025 finasteride Tablet, film coated 5 mg Current Limited Availability Manufacturing 1/12/2025 paclitaxel Injection, concentrated 300 mg Current Unavailable Manufacturing 1/12/2025 codeine phosphate hemihydrate Oral Liquid 5 mg/mL Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 1/12/2025 peramivir Injection, concentrated 10 mg/mL Current Unavailable Commercial Changes / Commercial viability 1/12/2025 moxonidine Tablet, film coated 200 microgram Anticipated Available Commercial Changes / Commercial viability 1/12/2025 lacosamide Tablet, film coated 100 mg Current Limited Availability Manufacturing 1/12/2025 lacosamide Tablet, film coated 50 mg Current Limited Availability Manufacturing 1/12/2025 aprepitant Capsule, hard 165 mg Anticipated Available Manufacturing 1/12/2025 montelukast sodium Tablet, chewable 5.2 mg Current Unavailable Manufacturing 1/12/2025 oseltamivir phosphate Capsule, hard 98.524 mg Resolved Available Manufacturing 1/12/2025 finasteride Tablet, film coated 1 mg Current Unavailable Manufacturing 1/12/2025 levothyroxine sodium Tablet, uncoated .05 mg Current Limited Availability Manufacturing 1/12/2025 tetrabenazine Tablet, uncoated 25 mg Current Unavailable Manufacturing 1/12/2025 lidocaine hydrochloride Injection, solution 10 mg/mL Current Limited Availability Manufacturing 1/12/2025 ropivacaine hydrochloride Injection, solution 10 mg/mL Current Limited Availability Manufacturing 1/12/2025 ropivacaine hydrochloride Injection, solution 7.5 mg/mL Current Limited Availability Manufacturing 1/12/2025 ropivacaine hydrochloride Injection, solution 7.5 mg/mL Current Unavailable Manufacturing 1/12/2025 cabergoline Tablet, uncoated 1 mg Anticipated Available Manufacturing 1/12/2025 dalteparin sodium Injection, solution 18000 anti-Xa IU Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 1/12/2025 dosulepin hydrochloride Tablet, film coated 75 mg Resolved Available Manufacturing 1/12/2025 reboxetine mesilate Tablet, uncoated 5.224 mg Anticipated Available Commercial Changes / Commercial viability 1/12/2025 - 2025.12.01
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated phenytoin sodium Injection, solution 250 mg Current Unavailable Manufacturing 28/11/2025 phenytoin sodium Injection, solution 100 mg Current Unavailable Manufacturing 28/11/2025 codeine phosphate hemihydrate Oral Liquid, solution 5 mg/mL Current Unavailable Manufacturing 28/11/2025 topiramate Tablet, film coated 25 mg Current Unavailable Manufacturing 28/11/2025 midazolam Injection, solution 5 mg/mL Current Limited Availability Manufacturing 28/11/2025 metformin hydrochloride Tablet, film coated 500 mg Resolved Available Manufacturing 28/11/2025 olanzapine Tablet, film coated 5 mg Current Unavailable Manufacturing 28/11/2025 olanzapine Tablet, film coated 7.5 mg Current Unavailable Manufacturing 28/11/2025 donepezil hydrochloride Tablet, film coated 5 mg Anticipated Available Manufacturing 28/11/2025 lamivudine Tablet, film coated 300 mg Anticipated Available Manufacturing 28/11/2025 levetiracetam Tablet, film coated 1000 mg Resolved Available Manufacturing 28/11/2025 sildenafil citrate Tablet, film coated 140.45 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 28/11/2025 ondansetron hydrochloride dihydrate Tablet, film coated 9.972 mg Current Limited Availability Manufacturing 28/11/2025 atorvastatin calcium trihydrate Tablet, film coated 21.69 mg Resolved Available Manufacturing 28/11/2025 indapamide hemihydrate Tablet, sugar coated 2.5 mg Current Unavailable Manufacturing 28/11/2025 montelukast sodium Tablet, chewable 4.16 mg Current Unavailable Manufacturing 28/11/2025 montelukast sodium Tablet, film coated 10.4 mg Anticipated Available Manufacturing 28/11/2025 montelukast sodium Tablet, chewable 4.16 mg Current Unavailable Manufacturing 28/11/2025 clopidogrel hydrogen sulfate Tablet, film coated 97.875 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 28/11/2025 finasteride Tablet, film coated 1 mg Resolved Available Manufacturing 28/11/2025 nystatin Oral Liquid, suspension 100000 IU/mL Resolved Available Unexpected increase in consumer demand 28/11/2025 pramipexole dihydrochloride monohydrate Tablet 1 mg Anticipated Available Manufacturing 28/11/2025 ezetimibe Tablet, uncoated 10 mg Resolved Available Unexpected increase in consumer demand 28/11/2025 ezetimibe Tablet, uncoated 10 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 28/11/2025 lamotrigine Tablet, uncoated 25 mg Current Limited Availability Commercial Changes / Commercial viability 28/11/2025 cyproterone acetate Tablet, uncoated 100 mg Anticipated Available Manufacturing 28/11/2025 tobramycin Inhalation, conventional 60 mg/mL Anticipated Available Manufacturing 28/11/2025 nizatidine Capsule, hard 150 mg Resolved Available Manufacturing 28/11/2025 Semaglutide Injection, solution 1.34 mg/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 28/11/2025 prasugrel Tablet, film coated 5 mg Current Unavailable Commercial Changes / Commercial viability 28/11/2025 lanreotide acetate Injection, solution 100 mg Anticipated Available Manufacturing 28/11/2025 clopidogrel hydrogen sulfate Tablet, film coated 97.875 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 28/11/2025 naltrexone hydrochloride Tablet, film coated 50 mg Anticipated Available Manufacturing 28/11/2025 levothyroxine sodium Tablet 200 microgram Resolved Available Unexpected increase in consumer demand 28/11/2025 atracurium besilate Injection, solution 10 mg/mL Anticipated Available Manufacturing 28/11/2025 mivacurium chloride Injection, solution 2.14 mg/mL Current Unavailable Manufacturing 28/11/2025 framycetin sulfate~gramicidin~dexamethasone Ear Drops 5 mg/mL~.05 mg/mL~.5 mg/mL Anticipated Available Manufacturing 28/11/2025 phenytoin sodium Injection, solution 100 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 28/11/2025 phenytoin sodium Injection, solution 250 mg Current Limited Availability Manufacturing 28/11/2025 cisatracurium besilate Injection, solution 6.7 mg/mL Anticipated Available Manufacturing 28/11/2025 naratriptan hydrochloride Tablet, film coated 2.78 mg Current Limited Availability Manufacturing 28/11/2025 pramipexole dihydrochloride monohydrate Tablet, uncoated 1 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 28/11/2025 valaciclovir hydrochloride Tablet, film coated 1112 mg Resolved Available Manufacturing 28/11/2025 risperidone Injection, modified release 50 mg Resolved Available Manufacturing 28/11/2025 verapamil hydrochloride Tablet, modified release 240 mg Resolved Available Manufacturing 27/11/2025 glimepiride Tablet, uncoated 2 mg Anticipated Available Manufacturing 27/11/2025 acetazolamide sodium Injection, powder for 549.5 mg Current Unavailable Manufacturing 27/11/2025 pentetic acid Injection, powder for 5 mg Current Unavailable Manufacturing 27/11/2025 lamotrigine Tablet, chewable 100 mg Current Limited Availability Manufacturing 27/11/2025 risperidone Tablet, film coated 2 mg Current Limited Availability Manufacturing 27/11/2025 methylphenidate hydrochloride Capsule, modified release 10 mg Resolved Available Manufacturing 27/11/2025 bisoprolol fumarate Tablet 2.5 mg Current Unavailable Manufacturing 27/11/2025 bisoprolol fumarate Tablet 10 mg Current Limited Availability Manufacturing 27/11/2025 levetiracetam Tablet, film coated 500 mg Current Limited Availability Manufacturing 27/11/2025 ropivacaine hydrochloride Injection, solution 2 mg/mL Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 27/11/2025 ropivacaine hydrochloride Injection, solution 7.5 mg/mL Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 27/11/2025 cobicistat~atazanavir Tablet, film coated 150 mg~300 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 27/11/2025 methylphenidate hydrochloride Capsule, modified release 60 mg Current Limited Availability Manufacturing 27/11/2025 risperidone Tablet, film coated 1 mg Anticipated Available Manufacturing 27/11/2025 risperidone Tablet, film coated 2 mg Anticipated Available Manufacturing 27/11/2025 letrozole Tablet, film coated 2.5 mg Resolved Available Manufacturing 27/11/2025 paclitaxel Injection, powder for 100 mg Current Limited Availability Manufacturing 27/11/2025 methylphenidate hydrochloride Capsule, hard 40 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 27/11/2025 methylphenidate hydrochloride Capsule, hard 20 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 27/11/2025 methylphenidate hydrochloride Capsule, hard 30 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 27/11/2025 methylphenidate hydrochloride Capsule, hard 10 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 27/11/2025 methylphenidate hydrochloride Capsule, hard 60 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 27/11/2025 methylphenidate hydrochloride Capsule, modified release 40 mg Current Unavailable Manufacturing 27/11/2025 lamotrigine Tablet, dispersible 100 mg Current Limited Availability Manufacturing 27/11/2025 lamotrigine Tablet, dispersible 200 mg Current Unavailable Manufacturing 27/11/2025 verapamil hydrochloride Tablet, film coated 240 mg Current Limited Availability Manufacturing 26/11/2025 valaciclovir Tablet, film coated 500 mg Current Limited Availability Manufacturing 26/11/2025 sodium pyrophosphate Injection, powder for 30 mg Current Unavailable Manufacturing 26/11/2025 risperidone Tablet 1 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 26/11/2025 losartan potassium Tablet, film coated 50 mg Current Unavailable Manufacturing 26/11/2025 losartan potassium Tablet, film coated 25 mg Current Unavailable Manufacturing 26/11/2025 mycophenolate mofetil Tablet, film coated 500 mg Current Limited Availability Manufacturing 26/11/2025 nystatin Oral Liquid 100000 IU/mL Resolved Available Commercial Changes / Commercial viability 26/11/2025 letrozole Tablet, film coated 2.5 mg Current Unavailable Manufacturing 26/11/2025 atorvastatin calcium trihydrate Tablet, film coated 21.69 mg Current Unavailable Manufacturing 26/11/2025 amlodipine besilate~atorvastatin calcium trihydrate Tablet, film coated 13.88 mg~10.844 mg Resolved Available Manufacturing 26/11/2025 midazolam Injection, solution 50 mg Current Unavailable Manufacturing 26/11/2025 flecainide acetate Tablet, uncoated 50 mg Current Limited Availability Manufacturing 26/11/2025 rosuvastatin calcium Tablet, film coated 20.84 mg Current Unavailable Unexpected increase in consumer demand 26/11/2025 pregabalin Capsule, hard 150 mg Current Limited Availability Unexpected increase in consumer demand 26/11/2025 pregabalin Capsule, hard 25 mg Resolved Available Manufacturing 26/11/2025 levetiracetam Solution 100 mg/mL Current Limited Availability Manufacturing 26/11/2025 atomoxetine hydrochloride Capsule, hard 20.57 mg Current Unavailable Manufacturing 26/11/2025 dabigatran etexilate mesilate Capsule, hard 172.95 mg Current Unavailable Manufacturing 26/11/2025 metaraminol tartrate Injection, solution 19 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 26/11/2025 tamoxifen citrate Tablet 30.34 mg Anticipated Available Manufacturing 26/11/2025 sunitinib Capsule 12.5 mg Anticipated Available Manufacturing 26/11/2025 tofacitinib citrate Solution 1.62 mg/mL Anticipated Available Manufacturing 26/11/2025 risperidone Oral Liquid, solution 1 mg/mL Current Unavailable Manufacturing 26/11/2025 ropivacaine hydrochloride Injection, solution 2 mg/mL Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 26/11/2025 vinorelbine tartrate Injection, concentrated 13.85 mg/mL Discontinued Unavailable Commercial Changes / Commercial viability 26/11/2025 vinorelbine tartrate Injection, concentrated 13.85 mg/mL Discontinued Unavailable Commercial Changes / Commercial viability 26/11/2025 clonidine hydrochloride Tablet, uncoated 150 microgram Anticipated Available Manufacturing 26/11/2025 methylphenidate hydrochloride Capsule, modified release 20 mg Current Limited Availability Manufacturing 26/11/2025 methylphenidate hydrochloride Capsule, modified release 30 mg Current Limited Availability Manufacturing 26/11/2025 flecainide acetate Injection, solution 10 mg/mL Resolved Available Transport / Logistic issues / Storage capacity issues 25/11/2025 lidocaine hydrochloride Gel 20 mg/g Resolved Available Manufacturing 25/11/2025 medronic acid Injection, powder for 10 mg Current Unavailable Manufacturing 25/11/2025 sodium fluoride Injection, concentrated 1 mg/mL Current Unavailable Manufacturing 25/11/2025 phenoxymethylpenicillin potassium Tablet, film coated 560 mg Resolved Available Manufacturing 25/11/2025 armodafinil Tablet, uncoated 150 mg Anticipated Available Transport / Logistic issues / Storage capacity issues 25/11/2025 pramipexole dihydrochloride monohydrate Tablet .25 mg Current Unavailable Unexpected increase in consumer demand 25/11/2025 enalapril maleate Tablet 5 mg Anticipated Available Manufacturing 24/11/2025 phenobarbital Tablet, uncoated 30 mg Current Unavailable Manufacturing 24/11/2025 hydrochlorothiazide~candesartan cilexetil Tablet, uncoated 12.5 mg~16 mg Anticipated Available Manufacturing 24/11/2025 lansoprazole Tablet, orally disintegrating 15 mg Current Unavailable Manufacturing 24/11/2025 lansoprazole Tablet, orally disintegrating 30 mg Current Unavailable Manufacturing 24/11/2025 tranexamic acid Tablet, film coated 500 mg Current Unavailable Manufacturing 24/11/2025 nizatidine Capsule, hard 150 mg Current Unavailable Manufacturing 24/11/2025 metformin hydrochloride Tablet, film coated 1000 mg Resolved Available Unexpected increase in consumer demand 24/11/2025 ondansetron hydrochloride dihydrate Tablet, film coated 9.972 mg Anticipated Available Manufacturing 24/11/2025 fenofibrate Tablet, film coated 145 mg Anticipated Available Manufacturing 24/11/2025 escitalopram oxalate Tablet, film coated 12.74 mg Resolved Available Commercial Changes / Commercial viability 24/11/2025 escitalopram oxalate Tablet, film coated 25.47 mg Resolved Available Manufacturing 24/11/2025 eplerenone Tablet, film coated 25 mg Current Limited Availability Manufacturing 24/11/2025 Rabies virus Injection, powder for 2.5 IU Resolved Available Unexpected increase in consumer demand 24/11/2025 metaraminol tartrate Injection, solution 19 mg Current Unavailable Manufacturing 24/11/2025 Tocilizumab Injection, solution 162 mg Resolved Available Manufacturing 24/11/2025 lanreotide acetate Injection, solution 66.67 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 24/11/2025 hydrocortisone hydrogen succinate Injection, powder for 127.6 mg Current Limited Availability Manufacturing 24/11/2025 mupirocin Ointment 20 mg/g Current Unavailable Manufacturing 24/11/2025 labetalol hydrochloride Tablet, film coated 100 mg Current Unavailable Manufacturing 24/11/2025 flunitrazepam Tablet, film coated 1 mg Current Limited Availability Manufacturing 24/11/2025 ciprofloxacin hydrochloride Tablet, film coated 582.21 mg Anticipated Available Manufacturing 24/11/2025 nizatidine Capsule, hard 300 mg Current Limited Availability Manufacturing 24/11/2025